<SEC-DOCUMENT>0001193125-24-020938.txt : 20240131
<SEC-HEADER>0001193125-24-020938.hdr.sgml : 20240131
<ACCEPTANCE-DATETIME>20240131161953
ACCESSION NUMBER:		0001193125-24-020938
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		18
CONFORMED PERIOD OF REPORT:	20240130
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20240131
DATE AS OF CHANGE:		20240131

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AMERICAN SUPERCONDUCTOR CORP /DE/
		CENTRAL INDEX KEY:			0000880807
		STANDARD INDUSTRIAL CLASSIFICATION:	MOTORS & GENERATORS [3621]
		ORGANIZATION NAME:           	04 Manufacturing
		IRS NUMBER:				042959321
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-19672
		FILM NUMBER:		24583179

	BUSINESS ADDRESS:	
		STREET 1:		SIXTY FOUR JACKSON ROAD
		CITY:			DEVENS
		STATE:			MA
		ZIP:			01434
		BUSINESS PHONE:		9788423000

	MAIL ADDRESS:	
		STREET 1:		SIXTY FOUR JACKSON ROAD
		CITY:			DEVENS
		STATE:			MA
		ZIP:			01434
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d739219d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-types="http://fasb.org/us-types/2023" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:amsc="http://www.amsc.com/20240130" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric id="Hidden_dei_EntityRegistrantName" name="dei:EntityRegistrantName" contextRef="duration_2024-01-30_to_2024-01-30">AMERICAN SUPERCONDUCTOR CORP /DE/</ix:nonNumeric> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2024-01-30_to_2024-01-30" id="ixv-307">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2024-01-30_to_2024-01-30">0000880807</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xlink:type="simple" xlink:href="amsc-20240130.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase"/> </ix:references> <ix:resources> <xbrli:context id="duration_2024-01-30_to_2024-01-30"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880807</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-30</xbrli:startDate> <xbrli:endDate>2024-01-30</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:8pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Washington, D.C. 20549</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:6pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <span style="white-space:nowrap"><ix:nonNumeric name="dei:DocumentType" contextRef="duration_2024-01-30_to_2024-01-30" id="ixv-318">8-K</ix:nonNumeric></span></p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:6pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section&#160;13 or 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of The Securities Exchange Act of 1934</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2024-01-30_to_2024-01-30" format="ixt:datemonthdayyearen" id="ixv-319">January&#160;30, 2024</ix:nonNumeric></p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:6pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"> <span style=" -sec-ix-hidden:Hidden_dei_EntityRegistrantName">American Superconductor Corporation</span> </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact name of registrant as specified in its charter)</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2024-01-30_to_2024-01-30" format="ixt-sec:stateprovnameen" id="ixv-320">Delaware</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2024-01-30_to_2024-01-30" id="ixv-321">000-19672</ix:nonNumeric></span></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2024-01-30_to_2024-01-30" id="ixv-322">04-2959321</ix:nonNumeric></span></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(State or other jurisdiction</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Commission</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(IRS Employer</span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">of incorporation)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">File Number)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">Identification No.)</span></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:50%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:48%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2024-01-30_to_2024-01-30" id="ixv-323">114 East Main Street</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2024-01-30_to_2024-01-30" id="ixv-324">Ayer</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2024-01-30_to_2024-01-30" format="ixt-sec:stateprovnameen" id="ixv-325">Massachusetts</ix:nonNumeric></p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:bottom"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2024-01-30_to_2024-01-30" id="ixv-326">01432</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Address of principal executive offices)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Zip Code)</span></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Registrant&#8217;s telephone number, including area code <ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2024-01-30_to_2024-01-30" id="ixv-327">(978)</ix:nonNumeric> <span style="white-space:nowrap"><ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2024-01-30_to_2024-01-30" id="ixv-328">842-3000</ix:nonNumeric></span></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Not Applicable</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Former name or former address, if changed since last report.)</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <span style="white-space:nowrap">8-K</span> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2024-01-30_to_2024-01-30" format="ixt-sec:boolballotbox" id="ixv-329">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2024-01-30_to_2024-01-30" format="ixt-sec:boolballotbox" id="ixv-330">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule <span style="white-space:nowrap">14a-12</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14a-12)</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2024-01-30_to_2024-01-30" format="ixt-sec:boolballotbox" id="ixv-331">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">14d-2(b)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14d-2(b))</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2024-01-30_to_2024-01-30" format="ixt-sec:boolballotbox" id="ixv-332">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">13e-4(c)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.13e-4(c))</span></p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Securities registered pursuant to Section&#160;12(b) of the Act:</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading<br/>Symbol(s)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2024-01-30_to_2024-01-30" id="ixv-333">Common Stock, $0.01 par value per share</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2024-01-30_to_2024-01-30" id="ixv-334">AMSC</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2024-01-30_to_2024-01-30" format="ixt-sec:exchnameen" id="ixv-335">Nasdaq Global Select Market</ix:nonNumeric></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule <span style="white-space:nowrap">12b-2</span> of the Securities Exchange Act of 1934 (&#167; <span style="white-space:nowrap">240.12b-2</span> of this chapter).</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:right">Emerging growth company&#8194;<ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2024-01-30_to_2024-01-30" format="ixt-sec:boolballotbox" id="ixv-336">&#9744;</ix:nonNumeric></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.&#8194;&#9744;</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#8201;8.01</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Other Events </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On January&#160;30, 2024, American Superconductor Corporation (the &#8220;Company&#8221;) entered into an underwriting agreement (the &#8220;Underwriting Agreement&#8221;) with Oppenheimer&#160;&amp; Co. Inc., as representative of the several underwriters named therein (collectively, the &#8220;Underwriters&#8221;), relating to the issuance and sale (the &#8220;Offering&#8221;) of 5,400,000 shares of the Company&#8217;s common stock, par value $0.01 per share (&#8220;Common Stock&#8221;). The public offering price in the Offering is $11.25 per share of Common Stock. The net proceeds to the Company from the Offering are expected to be approximately $56.6&#160;million, after deducting underwriting discounts and commissions and estimated offering expenses payable by the Company. The Company intends to use the net proceeds of the Offering for working capital and general corporate purposes. The closing of the Offering is expected to occur on or about February&#160;2, 2024, subject to the satisfaction of customary closing conditions. In addition, under the terms of the Underwriting Agreement, the Company has granted the Underwriters a <span style="white-space:nowrap">30-day</span> option to purchase up to 810,000 additional shares of Common Stock. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Offering is being made pursuant to the Company&#8217;s effective shelf registration statement on Form <span style="white-space:nowrap">S-3</span> (File <span style="white-space:nowrap">No.&#160;333-253611)</span> previously filed with and declared effective by the Securities and Exchange Commission (the &#8220;SEC&#8221;) and a prospectus supplement and accompanying prospectus filed with the SEC. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Underwriting Agreement contains customary representations, warranties and agreements by the Company, customary conditions to closing, indemnification obligations of the Company and the Underwriters, including for liabilities under the Securities Act of 1933, as amended, other obligations of the parties and termination provisions. The representations, warranties and covenants contained in the Underwriting Agreement were made only for purposes of such agreement and as of specific dates, were solely for the benefit of the parties to such agreement, and may be subject to limitations agreed upon by the contracting parties. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The foregoing description of the Underwriting Agreement is not complete and is qualified in its entirety by reference to the full text of the Underwriting Agreement, a copy of which is filed as Exhibit 1.1 to this Current Report on Form <span style="white-space:nowrap">8-K</span> (the &#8220;Current Report&#8221;) and is incorporated by reference herein. A copy of the opinion of Latham&#160;&amp; Watkins LLP relating to the legality of the issuance and sale of the shares of Common Stock is attached as Exhibit 5.1 to this Current Report. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This Current Report, including the exhibits attached hereto, does not constitute an offer to sell or the solicitation of an offer to buy any Company securities, and shall not constitute an offer, solicitation or sale in any jurisdiction in which such offering, solicitation or sale would be unlawful. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Forward-Looking Statements </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This Current Report contains forward-looking statements within the meaning of Section&#160;21E of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;). Such forward-looking statements include, among other things, the expected net proceeds from the offering and the anticipated use of net proceeds, and other statements containing the words &#8220;intends,&#8221; &#8220;believes,&#8221; &#8220;anticipates,&#8221; &#8220;plans,&#8221; &#8220;expects,&#8221; &#8220;will&#8221; and similar expressions. Such forward-looking statements represent management&#8217;s current expectations and are inherently uncertain. There are a number of important factors that could materially impact the value of the Company&#8217;s common stock or cause actual results to differ materially from those indicated by such forward-looking statements. These important factors include, but are not limited to: the risk and uncertainties associated with market conditions, as well as risks and uncertainties in the Company&#8217;s business, including those risks discussed under the caption &#8220;Risk Factors&#8221; in Part 1. Item 1A of the Company&#8217;s Annual Report on Form <span style="white-space:nowrap">10-K</span> for the fiscal year ended March&#160;31, 2023 and the Company&#8217;s other reports filed with the SEC. These important factors, among others, could cause actual results to differ materially from those indicated by forward-looking statements made herein and presented elsewhere by management from time to time. Any such forward-looking statements represent management&#8217;s estimates as of the date of this Current Report. While the Company may elect to update such forward-looking statements at some point in the future, the Company disclaims any obligation to do so, even if subsequent events cause its views to change. These forward-looking statements should not be relied upon as representing the Company&#8217;s views as of any date subsequent to the date of this Current Report. This caution is made under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. </p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#8201;9.01.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Financial Statements and Exhibits. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(d) Exhibits: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td/>

<td style="vertical-align:bottom;width:4%"/>
<td style="width:93%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Exhibit</p> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">No.</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Description</p></td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#8199;1.1*</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d739219dex11.htm">Underwriting Agreement, dated January&#160;30, 2024, by and between American Superconductor Corporation and Oppenheimer&#160;&amp; Co. Inc., as representative of the several underwriters named therein </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#8199;5.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d739219dex51.htm">Opinion of Latham&#160;&amp; Watkins LLP </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">23.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d739219dex51.htm">Consent of Latham&#160;&amp; Watkins LLP (included in Exhibit&#160;5.1) </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document.</td></tr>
</table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:2%;vertical-align:top" align="left">*</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Certain confidential portions of this Exhibit were omitted by means of marking such portions with brackets (&#8220;[***]&#8221;) because the identified confidential portions (i)&#160;are not material and (ii)&#160;is the type of information that the registrant treats as private or confidential. </p></td></tr></table> <p style="font-size:18pt; margin-top:0pt; margin-bottom:0pt">&#160;</p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURES </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0">


<tr>

<td style="width:45%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:4%"/>

<td style="vertical-align:bottom"/>
<td style="width:3%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:45%"/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" colspan="3">AMERICAN SUPERCONDUCTOR CORPORATION</td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom">Date: January&#160;31, 2024</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman;text-align:center">/S/ JOHN W. KOSIBA, JR.</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="center"><span style="font-weight:bold">John W. Kosiba, Jr.</span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="center"><span style="font-style:italic">Senior Vice President and Chief Financial Officer</span></td></tr>
</table>
</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>d739219dex11.htm
<DESCRIPTION>EX-1.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-1.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 1.1 </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">EXECUTION VERSION </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>5,400,000
Shares of Common Stock </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AMERICAN SUPERCONDUCTOR CORPORATION </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>UNDERWRITING AGREEMENT </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">January&nbsp;30, 2024 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Oppenheimer&nbsp;&amp; Co.
Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">as Representative of the several </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Underwriters named in
Schedule A hereto </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">c/o Oppenheimer&nbsp;&amp; Co. Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">85
Broad Street </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">New York, New York 10004 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dear Ladies and
Gentlemen: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1. <I>INTRODUCTORY</I>. American Superconductor Corporation, a Delaware corporation (the &#147;<B>Company</B>&#148;), proposes to sell,
pursuant to the terms of this Underwriting Agreement (the &#147;<B>Agreement</B>&#148;), to the several underwriters named in <U>Schedule A</U> hereto (the &#147;<B>Underwriters</B>,&#148; or, each, an &#147;<B>Underwriter</B>&#148;), for whom
Oppenheimer&nbsp;&amp; Co. Inc. is acting as representative (the &#147;<B>Representative</B>&#148;), an aggregate 5,400,000 shares (the &#147;<B>Firm Stock</B>&#148;) of the Company&#146;s common stock, $0.01 par value per share (the &#147;<B>Common
Stock</B>&#148;). The Company also proposes to sell to the Underwriters, upon the terms and conditions set forth in Section&nbsp;3 hereof, up to an additional 810,000 shares of Common Stock (the &#147;<B>Optional Stock</B>&#148;). The Firm Stock and
the Optional Stock are hereinafter collectively referred to as the &#147;<B>Stock</B>.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2. <I>REPRESENTATIONS AND WARRANTIES OF THE COMPANY</I>. The
Company represents and warrants to the several Underwriters, as of the date hereof and as of each Closing Date (as defined below), and agrees with the several Underwriters, that: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(a) <U>Registration Statement</U>. A registration statement of the Company on Form <FONT STYLE="white-space:nowrap">S-3</FONT> (File <FONT
STYLE="white-space:nowrap">No.&nbsp;333-253611),</FONT> as amended by Post-Effective Amendment No.&nbsp;1 filed with the Commission on June&nbsp;2, 2021 and Post-Effective Amendment No.&nbsp;2 filed with the Commission on June&nbsp;2, 2021
(including all amendments thereto, the &#147;<B>Initial Registration Statement</B>&#148;) in respect of the Stock has been filed with the Securities and Exchange Commission (the &#147;<B>Commission</B>&#148;) pursuant to Rule 415 under the
Securities Act of 1933, as amended (the &#147;<B>Securities Act</B>&#148;). The Company meets the requirements for use of Form <FONT STYLE="white-space:nowrap">S-3</FONT> under the Securities Act, and the rules and regulations of the Commission
thereunder (the &#147;<B>Rules and Regulations</B>&#148;). The Initial Registration Statement and any post-effective amendment thereto, each in the form heretofore delivered to you, and, excluding exhibits thereto, to you for each of the other
Underwriters, have been declared effective by the Commission in such form and meet the requirements of the Securities Act, and the Rules and Regulations. The proposed offering of the Stock may be made pursuant to General Instruction I.B.1 of Form <FONT
STYLE="white-space:nowrap">S-3.</FONT> Other than (i)&nbsp;the Initial Registration Statement, (ii)&nbsp;a registration statement, if any, increasing the size of the offering filed pursuant to Rule 462(b) under the Securities Act and the Rules and
Regulations (a &#147;<B>Rule 462(b) Registration Statement</B>&#148;), (iii) any Preliminary Prospectus (as defined below), (iv) the Prospectus (as defined below) contemplated by this Agreement to be filed pursuant to Rule 424(b) of the Rules and
Regulations in accordance with Section&nbsp;4(a) hereof and (v)&nbsp;any Issuer Free Writing Prospectus (as defined below), no other document with respect to the offer and sale of the Stock has heretofore been filed with the Commission. No stop
order suspending the effectiveness of the Initial Registration Statement, any post-effective amendment thereto or the Rule 462(b) Registration Statement, if any, has been issued and no proceeding for that purpose or pursuant to Section&nbsp;8A of
the Securities Act has been initiated or, to the knowledge of the Company, threatened by the Commission (the Base Prospectus (as defined herein) and any preliminary prospectus supplement included in the Initial Registration Statement or filed with
the Commission pursuant to Rule 424 of the Rules and Regulations is hereinafter called a &#147;<B>Preliminary Prospectus</B>&#148;). The Initial Registration Statement, including all exhibits thereto and including the information contained in the
Prospectus filed with the Commission pursuant to Rule 424(b) of the Rules and Regulations and deemed by virtue of Rules 430A, 430B and 430C under the Securities Act to be part of the Initial Registration Statement at the time it became effective, is
hereinafter collectively called the &#147;<B>Registration Statement</B>.&#148; If the Company has filed a Rule 462(b) Registration Statement, then any reference herein to the term &#147;Registration Statement&#148; shall be deemed to include such
Rule 462 Registration Statement. The base prospectus included in the Initial Registration Statement at the time of effectiveness thereof (the &#147;<B>Base Prospectus</B>&#148;), as supplemented by the final prospectus supplement relating to the
offer and sale of the Stock, in the form filed pursuant to and within the time limits described in Rule 424(b) under the Rules and Regulations, is hereinafter called the &#147;<B>Prospectus</B>.&#148; </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Any reference herein to the Registration Statement, Preliminary Prospectus or the Prospectus shall be deemed
to refer to and include the documents incorporated by reference therein. Any reference to any amendment or supplement to any Preliminary Prospectus or the Prospectus shall be deemed to refer to and include any documents filed after the date of such
Preliminary Prospectus or the Prospectus under the Securities Exchange Act of 1934, as amended (the &#147;<B>Exchange Act</B>&#148;), and incorporated by reference in such Preliminary Prospectus or Prospectus, as the case may be. Any reference to
the effective date of such Registration Statement shall be deemed to refer to and include the date such Registration Statement became effective and, if later, the date the annual report of the last completed fiscal year of the Company on Form <FONT
STYLE="white-space:nowrap">10-K</FONT> was filed. Any reference to any amendment to the Registration Statement shall be deemed to refer to and include any annual report of the Company filed pursuant to Section&nbsp;13(a) or 15(d) of the Exchange Act
after the date of this Agreement that is incorporated by reference in the Registration Statement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(b) <U>General Disclosure Package</U>. As of the
Applicable Time (as defined below) and as of the Closing Date or the Option Closing Date (as defined below), as the case may be, neither (i)&nbsp;the Issuer Free Writing Prospectus(es) (as defined below) issued at or prior to the Applicable Time,
the Pricing Prospectus (as defined below) and the information included on <U>Schedule C</U> hereto, if any, all considered together (collectively, the &#147;<B>General Disclosure Package</B>&#148;), nor (ii)&nbsp;the bona fide electronic roadshow
(as defined in Rule 433(h)(5) of the Rules and Regulations), when considered together with the General Disclosure Package, included or will include any untrue statement of a material fact or omitted or will omit to state a material fact necessary in
order to make the statements therein, in the light of the circumstances under which they were made, not misleading; <I>provided, however</I>, that the Company makes no representations or warranties as to information contained in or omitted from the
Pricing Prospectus or any Issuer Free Writing Prospectus (as defined below), in reliance upon, and in conformity with, written information furnished to the Company through the Representative by or on behalf of any Underwriter specifically for
inclusion therein, which information the parties hereto agree is limited to the Underwriters&#146; Information (as defined in Section&nbsp;17). As used in this paragraph (b)&nbsp;and elsewhere in this Agreement: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B>Applicable Time</B>&#148; means 8:20 P.M., New York time, on the date of this Agreement or such other time as agreed to by the Company and the
Representative. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B>Pricing Prospectus</B>&#148; means the most recent Preliminary Prospectus relating to the Stock including the Base Prospectus,
as amended and supplemented immediately prior to the Applicable Time, including any document incorporated by reference therein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B>Issuer Free
Writing Prospectus</B>&#148; means any &#147;issuer free writing prospectus,&#148; as defined in Rule 433 of the Rules and Regulations relating to the Stock in the form filed or required to be filed with the Commission or, if not required to be
filed, in the form retained in the Company&#146;s records pursuant to Rule 433(g) of the Rules and Regulations that is identified on <U>Schedule B</U> to this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(c) <U>No Stop Orders; No Material Misstatements</U>. No order preventing or suspending the use of any Preliminary Prospectus, any Issuer Free Writing
Prospectus or the Prospectus relating to the proposed offering of the Stock has been issued by the Commission, and no proceeding for that purpose or pursuant to Section&nbsp;8A of the Securities Act has been instituted or threatened by the
Commission, and each Preliminary Prospectus, at the time of filing thereof, conformed in all material respects to the requirements of the Securities Act and the Rules and Regulations, and did not contain an untrue statement of a material fact or
omit to state a material fact required to be stated therein or necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading; <I>provided, however</I>, that the Company makes no
representations or warranties as to information contained in or omitted from any Preliminary Prospectus, in reliance upon, and in conformity with, written information furnished to the Company through the Representative by or on behalf of any
Underwriter specifically for inclusion therein, which information the parties hereto agree is limited to the Underwriters&#146; Information. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(d)
<U>Registration Statement and Prospectus Contents</U>. At the respective times the Registration Statement and any amendments thereto became or become effective as to the Underwriters and at each Closing Date, the Registration Statement and any
amendments thereto conformed and will conform in all material respects to the requirements of the Securities Act and the Rules and Regulations and did not and will not contain any untrue statement of a material fact or omit to state any material
fact required to be stated therein or necessary to make the statements therein not misleading; and the Prospectus and any amendments or supplements thereto, at the time the Prospectus or any amendment or supplement thereto was issued and at each
Closing Date, conformed and will conform in all material respects to the requirements of the Securities Act and the Rules and Regulations and did not and will not contain an untrue statement of a material fact or omit to state a material fact
necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading;<I> provided</I>, <I>however</I>, that the foregoing representations and warranties in this paragraph (d)&nbsp;shall not
apply to information contained in or omitted from the Registration Statement or the Prospectus, or any amendment or supplement thereto, in reliance upon, and in conformity with, written information furnished to the Company through the Representative
by or on behalf of any Underwriter specifically for inclusion therein, which information the parties hereto agree is limited to the Underwriters&#146; Information. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(e) <U>Issuer Free Writing Prospectus</U>. Each Issuer Free Writing Prospectus, as of its issue date and at
all subsequent times through the completion of the public offer and sale of the Stock or until any earlier date that the Company notified or notifies the Representative as described in Section&nbsp;4(f), did not, does not and will not include any
information that conflicted, conflicts or will conflict with the information contained in the Registration Statement, the Pricing Prospectus or the Prospectus, including any document incorporated by reference therein and any prospectus supplement
deemed to be a part thereof that has not been superseded or modified, or included or would include an untrue statement of a material fact or omitted or would omit to state a material fact required to be stated therein or necessary in order to make
the statements therein, in the light of the circumstances under which they were made, not misleading;<I> provided</I>, <I>however</I>, that the foregoing representations and warranties in this paragraph (e)&nbsp;shall not apply to information
contained in or omitted from the Registration Statement, the Pricing Prospectus or the Prospectus, or any amendment or supplement thereto, in reliance upon, and in conformity with, written information furnished to the Company through the
Representative by or on behalf of any Underwriter specifically for inclusion therein, which information the parties hereto agree is limited to the Underwriters&#146; Information. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(f) <U>Documents Incorporated by Reference.</U><I> </I>The documents incorporated by reference in the Registration Statement, General Disclosure Package and
Prospectus, when they were or hereafter are filed with the Commission, complied and will comply in all material respects to the requirements of the Securities Act or the Exchange Act, as applicable, and the rules and regulations of the Commission
thereunder and none of such documents contained or will contain any untrue statement of a material fact or omitted or will omit to state any material fact required to be stated therein, or necessary to make the statements therein, in the light of
the circumstances under which they were made, not misleading; and any further documents so filed and incorporated by reference in the Registration Statement, General Disclosure Package and Prospectus, when such documents are filed with Commission
will conform in all material respects to the requirements of the Securities Act or the Exchange Act, as applicable, and the rules and regulations of the Commission thereunder and will not contain any untrue statement of a material fact or omit to
state any material fact required to be stated therein or necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(g) <U>Distribution of Offering Materials</U>. The Company has not, directly or indirectly, distributed and will not distribute any offering material in
connection with the offering and sale of the Stock other than any Preliminary Prospectus, the Prospectus and other materials, if any, permitted under the Securities Act and consistent with Section&nbsp;4(b) below. The Company will file with the
Commission all Issuer Free Writing Prospectuses (other than a &#147;road show&#148; as described in Rule 433(d)(8) of the Rules and Regulations) in the time and manner required under Rules 163(b)(2) and 433(d) of the Rules and Regulations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(h) <U>Not an Ineligible Issuer</U>. At the time of filing the Initial Registration Statement, any Rule 462(b) Registration Statement and any post-effective
amendments thereto, and at the date hereof, the Company was not, and the Company currently is not, an &#147;ineligible issuer,&#148; as defined in Rule 405 of the Rules and Regulations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(i) <U>Financial Information.</U> The consolidated financial statements of the Company included or incorporated by reference in the Registration Statement,
the General Disclosure Package, the Prospectus and the Issuer Free Writing Prospectuses, if any, together with the related notes and schedules, present fairly, in all material respects, the consolidated financial position of the Company and the
Subsidiaries (as defined below) as of the dates indicated and the consolidated results of operations, cash flows and changes in stockholders&#146; equity of the Company for the periods specified and have been prepared in compliance in all material
respects with the requirements of the Securities Act and Exchange Act, as applicable, and in conformity with generally accepted accounting principles in the United States (&#147;<B>GAAP</B>&#148;) applied on a consistent basis (except (i)&nbsp;as
may be otherwise noted therein, (ii)&nbsp;in the case of unaudited interim financial statements, to the extent that they may not include footnotes required by GAAP or may be condensed or summary statements and (iii)&nbsp;for such adjustments which
will not be material, either individually or in the aggregate) during the periods involved; the other financial data with respect to the Company and the Subsidiaries contained or incorporated by reference in the Registration Statement, the General
Disclosure Package, the Prospectus and the Issuer Free Writing Prospectuses, if any, are accurately and fairly presented and prepared on a basis consistent with the financial statements and books and records of the Company; there are no financial
statements (historical or pro forma) that are required to be included or incorporated by reference in the Registration Statement, the General Disclosure Package or the Prospectus that are not included or incorporated by reference as required; the
Company and the Subsidiaries do not have any material liabilities or obligations, direct or contingent (including any <FONT STYLE="white-space:nowrap">off-balance</FONT> sheet obligations), not described in the Registration Statement (including the
exhibits thereto and documents incorporated by reference therein), the General Disclosure Package, and the Prospectus which are required to be described in the Registration Statement, the General Disclosure Package or the Prospectus (including
exhibits thereto and documents incorporated by reference therein); and all disclosures contained or incorporated by reference in the Registration Statement, the General Disclosure Package, the Prospectus and the Issuer Free Writing Prospectuses, if
any, regarding <FONT STYLE="white-space:nowrap">&#147;non-GAAP</FONT> financial measures&#148; (as such term is defined by the rules and regulations of the Commission) comply in all material respects with Regulation G of the Exchange Act and Item 10
of Regulation <FONT STYLE="white-space:nowrap">S-K</FONT> under the Securities Act, to the extent applicable. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(j) <U>Organization.</U> The Company and any subsidiary that is a significant subsidiary (as such term is
defined in Rule <FONT STYLE="white-space:nowrap">1-02(w)</FONT> of Regulation <FONT STYLE="white-space:nowrap">S-X</FONT> promulgated by the Commission) (each, a &#147;<B>Subsidiary</B>&#148;, collectively, the &#147;<B>Subsidiaries</B>&#148;), are
duly organized, validly existing as a corporation and in good standing under the laws of their respective jurisdictions of organization. The Company and the Subsidiaries are duly licensed or qualified as a foreign corporation for transaction of
business and in good standing under the laws of each other jurisdiction in which their respective ownership or lease of property or the conduct of their respective businesses requires such license or qualification, and have all corporate power and
authority necessary to own or hold their respective properties and to conduct their respective businesses as described in the Registration Statement, the General Disclosure Package and the Prospectus, except where the failure to be so qualified or
in good standing or have such power or authority would not, individually or in the aggregate, have a material adverse effect or would reasonably be expected to have a material adverse effect on the assets, business, operations, earnings, properties,
condition (financial or otherwise), prospects, stockholders&#146; equity or results of operations of the Company and the Subsidiaries taken as a whole, or prevent the consummation of the transactions contemplated hereby (a &#147;<B>Material Adverse
Effect</B>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(k) <U>Subsidiaries.</U> As of the date hereof, the Company&#146;s only Subsidiaries are set forth on <U>Schedule E</U>. Except as set
forth in the Registration Statement, the General Disclosure Package and the Prospectus, the Company owns directly or indirectly, all of the equity interests of the Subsidiaries free and clear of any lien, charge, security interest, encumbrance,
right of first refusal or other restriction, and all the equity interests of the Subsidiaries are validly issued and are fully paid, nonassessable and free of preemptive and similar rights. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(l) <U>No Violation or Default.</U> Neither the Company nor any Subsidiary is (i)&nbsp;in violation of its charter or
<FONT STYLE="white-space:nowrap">by-laws</FONT> or similar organizational documents; (ii)&nbsp;in default, and no event has occurred that, with notice or lapse of time or both, would constitute such a default, in the due performance or observance of
any term, covenant or condition contained in any indenture, mortgage, deed of trust, loan agreement or other agreement or instrument to which the Company or any Subsidiary is a party or by which the Company or any Subsidiary is bound or to which any
of the property or assets of the Company or any Subsidiary is subject; or (iii)&nbsp;in violation of any law or statute or any judgment, order, rule or regulation of any court or arbitrator or governmental or regulatory authority having jurisdiction
over the Company, except, in the case of each of clauses (ii)&nbsp;and (iii) above, for any such violation or default that would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. To the Company&#146;s
knowledge, no other party under any material contract or other agreement to which it or any Subsidiary is a party is in default in any respect thereunder where such default would reasonably be expected to have a Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(m) <U>eXtensible Business Reporting Language</U>. The interactive data in eXtensible Business Reporting Language included or incorporated by reference in the
Registration Statement, the General Disclosure Package and the Prospectus fairly presents the information called for in all material respects and has been prepared in accordance with the Commission&#146;s rules and guidelines applicable thereto.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(n) <U>No Material Adverse Effect.</U> Since the date of the most recent financial statements of the Company included or incorporated by reference in the
Registration Statement, the General Disclosure Package and the Prospectus, there has not been (i)&nbsp;any Material Adverse Effect, or any development involving a prospective Material Adverse Effect, in or affecting the business, properties,
management, condition (financial or otherwise), results of operations, or prospects of the Company and the Subsidiaries taken as a whole, (ii)&nbsp;any transaction which is material to the Company and the Subsidiaries taken as a whole (other than as
publicly announced), (iii) any obligation or liability, direct or contingent (including any <FONT STYLE="white-space:nowrap">off-balance</FONT> sheet obligations), incurred by the Company or the Subsidiaries, which is material to the Company and the
Subsidiaries taken as a whole, (iv)&nbsp;any material change in the capital stock (other than (A)&nbsp;the grant of additional options or awards under the Company&#146;s existing stock option plans, stock incentive plans or stock purchase plan
(B)&nbsp;changes in the number of outstanding Common Stock of the Company due to the issuance of shares upon the exercise or conversion of securities exercisable for, or convertible into, Common Stock outstanding on the date hereof, (C)&nbsp;any
repurchases of capital stock of the Company, (D)&nbsp;as described in a proxy statement filed on Schedule 14A or a Registration Statement on Form <FONT STYLE="white-space:nowrap">S-4,</FONT> or (E)&nbsp;otherwise publicly announced) or outstanding
long-term indebtedness of the Company or the Subsidiaries or (v)&nbsp;any dividend or distribution of any kind declared, paid or made on the capital stock of the Company or any Subsidiary, other than in each case above in the ordinary course of
business, or as otherwise disclosed in the General Disclosure Package (including any document deemed incorporated by reference therein). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(o)
<U>Capitalization.</U> The issued and outstanding shares of capital stock of the Company have been validly issued, are fully paid and <FONT STYLE="white-space:nowrap">non-assessable</FONT> and, other than as disclosed in the Registration Statement,
the General Disclosure Package and the Prospectus, are not subject to any preemptive rights, rights of first refusal or similar rights. The Company has an authorized, issued and outstanding capitalization as set forth in the Pricing Prospectus and
such authorized capital stock conforms to the description thereof set forth in the Registration Statement, the General Disclosure Package and the Prospectus. The description of the Common Stock in the Registration Statement, the General Disclosure
Package and the Prospectus is complete and accurate in all material respects. As of the date referred to therein, and except as set forth in the Registration Statement, the General Disclosure Package and the Prospectus, the Company did not have
outstanding any options to purchase, or any rights or warrants to subscribe for, or any securities or obligations convertible into, or exchangeable for, or any contracts or commitments to issue or sell, any shares of capital stock or other
securities. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(p) <U>Authorization; Enforceability.</U> The Company has corporate power and authority to enter into this
Agreement and perform the transactions contemplated hereby. This Agreement has been duly authorized, executed and delivered by the Company, and is a valid and binding agreement of the Company, enforceable against the Company in accordance with its
terms, except to the extent that (i)&nbsp;enforceability thereof may be limited by bankruptcy, insolvency, reorganization, moratorium or similar laws affecting creditors&#146; rights generally and by general equitable principles and (ii)&nbsp;the
indemnification and contribution provisions of Section&nbsp;7 hereof may be limited by federal or state securities laws and public policy considerations in respect thereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(q) <U>Authorization of Stock.</U> The Stock to be issued and sold by the Company to the Underwriters hereunder has been duly and validly authorized and, when
issued and delivered against payment therefor as provided herein, will be duly and validly issued, fully paid and <FONT STYLE="white-space:nowrap">non-assessable</FONT> and will conform to the descriptions thereof in the Registration Statement, the
General Disclosure Package and the Prospectus; and the issuance of the Stock is not subject to any preemptive or similar rights. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(r) <U>No Consents
Required; FINRA.</U> No consent, approval, authorization, order, registration or qualification of or with any court or arbitrator or any governmental or regulatory authority having jurisdiction over the Company is required for the execution,
delivery and performance by the Company of this Agreement, and the issuance and sale by the Company of the Stock as contemplated hereby, except for such consents, approvals, authorizations, orders and registrations or qualifications as may be
required under applicable state securities laws or by the <FONT STYLE="white-space:nowrap">by-laws</FONT> and rules of the Financial Industry Regulatory Authority (&#147;<B>FINRA</B>&#148;) or The Nasdaq Global Select Market, including any notices
that may be required by The Nasdaq Global Select Market, in connection with the issuance and sale of the Stock or the consummation of the transactions as contemplated by this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(s) <U>No Preferential Rights.</U> Except as provided for in this Agreement, (i)&nbsp;no person, as such term is defined in Rule <FONT
STYLE="white-space:nowrap">1-02</FONT> of Regulation <FONT STYLE="white-space:nowrap">S-X</FONT> promulgated under the Securities Act (each, a &#147;<B>Person</B>&#148;), has the right, contractual or otherwise, to cause the Company to issue or sell
to such Person any Common Stock or shares of any other capital stock or other securities of the Company (other than upon the exercise of options or warrants to purchase Common Stock or upon the exercise of options or award that may be granted from
time to time under the Company&#146;s stock option plans, stock incentive plans or stock purchase plan), (ii) no Person has any preemptive rights or rights of first refusal (whether pursuant to a &#147;poison pill&#148; provision or otherwise) to
purchase any Common Stock or shares of any other capital stock or other securities of the Company from the Company which have not been duly waived with respect to the offering contemplated hereby, (iii)&nbsp;no Person has the right to act as an
underwriter or as a financial advisor to the Company in connection with the offer and sale of the Common Stock, and (iv)&nbsp;no Person has the right, contractual or otherwise, to require the Company to register under the Securities Act any Common
Stock or shares of any other capital stock or other securities of the Company, or to include any such shares or other securities in the Registration Statement or the offering contemplated thereby, whether as a result of the filing or effectiveness
of the Registration Statement or otherwise that has not been waived by such Person. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(t) <U>Independent Public Accountant.</U> RSM US LLP (the
&#147;<B>Accountant</B>&#148;), whose report on the consolidated financial statements of the Company is filed with the Commission as part of the Company&#146;s most recent Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> filed with
the Commission and incorporated into the Registration Statement, the General Disclosure Package and the Prospectus, are and, during the periods covered by their report, were independent public accountants within the meaning of the Securities Act and
the Public Company Accounting Oversight Board (United States). To the Company&#146;s knowledge, with due inquiry, the Accountant is not in violation of the auditor independence requirements of the Sarbanes-Oxley Act of 2002 (the
&#147;<B>Sarbanes-Oxley Act</B>&#148;) with respect to the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(u) <U>Enforceability of Agreements.</U> All agreements between the Company and third
parties expressly referenced in the Registration Statement, the General Disclosure Package, and the Prospectus, other than such agreements that have expired by their terms or whose termination is disclosed in documents filed by the Company on EDGAR,
are valid and binding obligations of the Company enforceable in accordance with their respective terms, except to the extent that (i)&nbsp;enforceability may be limited by bankruptcy, insolvency, reorganization, moratorium or similar laws affecting
creditors&#146; rights generally and by general equitable principles and (ii)&nbsp;the indemnification provisions of certain agreements may be limited by federal or state securities laws or public policy considerations in respect thereof, and except
for any unenforceability that, individually or in the aggregate, would not unreasonably be expected to have a Material Adverse Effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(v) <U>No
Litigation.</U> Except as set forth in the Registration Statement, the General Disclosure Package and the Prospectus, there are no legal, governmental or regulatory actions, suits or proceedings pending, nor, to the Company&#146;s knowledge, any
legal, governmental or regulatory investigations, to which the Company or a Subsidiary is a party or to which any property of the Company or any Subsidiary is the subject that, individually or in the aggregate, if determined adversely to the Company
or any Subsidiary, would reasonably be expected to have a Material Adverse Effect or materially and adversely affect the ability of the Company to perform its obligations under this Agreement; to the Company&#146;s knowledge, no such actions, suits
or proceedings are threatened or contemplated by any governmental or regulatory authority or threatened by others that, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
individually or in the aggregate, if determined adversely to the Company or any Subsidiary, would reasonably be expected to have a Material Adverse Effect; and (i)&nbsp;there are no current or
pending legal, governmental or regulatory actions, suits or proceedings or, to the Company&#146;s knowledge, investigations that are required under the Securities Act to be described in the Registration Statement, the General Disclosure Package, or
the Prospectus that are not so described, including any document incorporated by reference; and (ii)&nbsp;there are no contracts or other documents that are required under the Securities Act to be filed as exhibits to the Registration Statement that
are not so filed, except with respect to those exhibits included in the Company&#146;s Current Report on Form <FONT STYLE="white-space:nowrap">8-K</FONT> to be filed in connection with this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(w) <U>Licenses and Permits.</U> The Company and the Subsidiaries possess or have obtained, all licenses, certificates, consents, orders, approvals, permits
and other authorizations issued by, and have made all declarations and filings with, the appropriate federal, state, local or foreign governmental or regulatory authorities that are necessary for the ownership or lease of their respective properties
or the conduct of their respective businesses as described in the Registration Statement, the General Disclosure Package and the Prospectus (the &#147;<B>Permits</B>&#148;), except where the failure to possess, obtain or make the same would not,
individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. Neither the Company nor any Subsidiary have received written notice of any proceeding relating to revocation or modification of any such Permit or has any
reason to believe that such Permit will not be renewed in the ordinary course, except where the failure to obtain any such renewal would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(x) <U>No Material Defaults.</U> Neither the Company nor any Subsidiary has defaulted on any installment on indebtedness for borrowed money or on any rental
on one or more long-term leases, which defaults, individually or in the aggregate, could reasonably be expected to have a Material Adverse Effect. The Company has not filed a report pursuant to Section&nbsp;13(a) or 15(d) of the Exchange Act since
the filing of its Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the year ended March&nbsp;31, 2023, indicating that it (i)&nbsp;has failed to pay any dividend or sinking fund installment on preferred stock or (ii)&nbsp;has
defaulted on any installment on indebtedness for borrowed money or on any rental on one or more long-term leases, which defaults, individually or in the aggregate, would reasonably be expected to have a Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(y) <U>Certain Market Activities.</U> Neither the Company, nor any Subsidiary, nor to the Company&#146;s knowledge, any of their respective directors,
officers, or controlling persons has taken or will take, directly or indirectly, any action designed, or that has constituted or would reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or
manipulation of the price of any security of the Company to facilitate the sale or resale of the Stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(z) <U>Broker/Dealer Relationships.</U> Neither
the Company nor any Subsidiary or any related entities (i)&nbsp;is required to register as a &#147;broker&#148; or &#147;dealer&#148; in accordance with the provisions of the Exchange Act or (ii)&nbsp;directly or indirectly through one or more
intermediaries, controls or is a &#147;person associated with a member&#148; or &#147;associated person of a member&#148; (within the meaning set forth in the FINRA Manual). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(aa) <U>Taxes.</U> The Company and the Subsidiaries have filed all federal, state, local and foreign tax returns which have been required to be filed and paid
all taxes shown thereon through the date hereof, to the extent that such taxes have become due and are not being contested in good faith, except where the failure to do so would not reasonably be expected to have a Material Adverse Effect. Except as
otherwise disclosed in or contemplated by the Registration Statement, the General Disclosure Package or the Prospectus, no tax deficiency has been determined adversely to the Company or any Subsidiary which has had, or would reasonably be expected
to have, individually or in the aggregate, a Material Adverse Effect. The Company has no knowledge of any federal, state or other governmental tax deficiency, penalty or assessment which has been or might be asserted or threatened against it which
could have a Material Adverse Effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(bb) <U>Title to Real and Personal Property.</U> The Company and the Subsidiaries have good and valid title in fee
simple to all items of real property and good and valid title to all personal property described in the Registration Statement, the General Disclosure Package or Prospectus as being owned by them that are material to the businesses of the Company or
such Subsidiary, in each case free and clear of all liens, encumbrances and claims, except those that (i)&nbsp;do not materially interfere with the use made and proposed to be made of such property by the Company and the Subsidiaries or
(ii)&nbsp;would not reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect. Any real property described in the Registration Statement, the General Disclosure Package or Prospectus as being leased by the Company
and the Subsidiaries is held by them under valid, existing and enforceable leases, except those that (A)&nbsp;do not materially interfere with the use made or proposed to be made of such property by the Company or the Subsidiaries or (B)&nbsp;would
not be reasonably expected, individually or in the aggregate, to have a Material Adverse Effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(cc) <U>Intellectual Property.</U> Except as set forth
in the Registration Statement, the General Disclosure Package and the Prospectus, (i)&nbsp;to the Company&#146;s knowledge, the Company and the Subsidiaries own or possess adequate enforceable rights to use all patents, patent applications,
trademarks (both registered and unregistered), service marks, trade names, trademark registrations, service mark registrations, copyrights, copyright registrations, licenses, Internet domain names, Internet domain name registrations, inventions,
software, works of authorships, databases formulae and <FONT STYLE="white-space:nowrap">know-how</FONT> (including trade secrets, trade secret rights and other unpatented and/or unpatentable proprietary or confidential information, systems or
procedures) </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
(collectively, the &#147;<B>Intellectual Property</B>&#148;), necessary for the conduct of their respective businesses as conducted as of the date hereof, except to the extent that the failure to
own or possess adequate rights to use such Intellectual Property would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect; (ii)&nbsp;the Company and the Subsidiaries have not received any written notice
of any claim of infringement or conflict which asserted Intellectual Property rights of others, which infringement or conflict, if the subject of an unfavorable decision, would reasonably be expected to result in a Material Adverse Effect;
(iii)&nbsp;there are no pending, or to the Company&#146;s knowledge, threatened judicial proceedings or interference proceedings against the Company or its Subsidiaries challenging the Company&#146;s or any of its Subsidiary&#146;s rights in or to
or the validity of the scope of any of the Company&#146;s or any Subsidiary&#146;s patents, patent applications or proprietary information; (iv)&nbsp;to the Company&#146;s knowledge, no other entity or individual has any right or claim in any of the
Company&#146;s or any of its Subsidiary&#146;s patents, patent applications or any patent to be issued therefrom by virtue of any contract, license or other agreement entered into between such entity or individual and the Company or any Subsidiary
or by any <FONT STYLE="white-space:nowrap">non-contractual</FONT> obligation, other than by written licenses granted by the Company or any Subsidiary; and (v)&nbsp;the Company and the Subsidiaries have not received any written notice of any claim
challenging the rights of the Company or its Subsidiaries in or to any Intellectual Property owned, licensed or optioned by the Company or any Subsidiary which claim, if the subject of an unfavorable decision would result in a Material Adverse
Effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(dd) <U>Environmental Laws.</U> The Company and the Subsidiaries (i)&nbsp;are in compliance with any and all applicable federal, state, local and
foreign laws, rules, regulations, decisions and orders relating to the protection of human health and safety, the environment or hazardous or toxic substances or wastes, pollutants or contaminants (collectively, &#147;<B>Environmental
Laws</B>&#148;); (ii) have received and are in compliance in with all permits, licenses or other approvals required of them under applicable Environmental Laws to conduct their respective businesses as described in the Registration Statement, the
General Disclosure Package and the Prospectus; and (iii)&nbsp;have not received notice of any actual or potential liability for the investigation or remediation of any disposal or release of hazardous or toxic substances or wastes, pollutants or
contaminants, except, in the case of any of clauses (i), (ii) or (iii)&nbsp;above, for any such failure to comply or failure to receive required permits, licenses, other approvals or liability as would not, individually or in the aggregate,
reasonably be expected to have a Material Adverse Effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(ee) <U>Accounting Controls and Disclosure Controls.</U> The Company and each of its
subsidiaries maintain effective internal control over financial reporting (as defined under Exchange Act Rules <FONT STYLE="white-space:nowrap">13a-15</FONT> and <FONT STYLE="white-space:nowrap">15d-15)</FONT> and a system of internal accounting
controls designed to provide reasonable assurance that (i)&nbsp;transactions are executed in accordance with management&#146;s general or specific authorizations; (ii)&nbsp;transactions are recorded as necessary to permit preparation of financial
statements in conformity with GAAP and to maintain asset accountability; (iii)&nbsp;access to assets is permitted only in accordance with management&#146;s general or specific authorization; and (iv)&nbsp;the recorded accountability for assets is
compared with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences. The Company is not aware of any material weaknesses in its internal control over financial reporting (other than as set forth
in the Registration Statement, the General Disclosure Package and the Prospectus). Since the date of the latest audited financial statements of the Company included in the Registration Statement, the General Disclosure Package and the Prospectus,
there has been no change in the Company&#146;s internal control over financial reporting that has materially affected, or is reasonably likely to materially affect, the Company&#146;s internal control over financial reporting (other than as set
forth in the Registration Statement, the General Disclosure Package and the Prospectus). The Company and each of its subsidiaries maintain an effective system of disclosure controls and procedures (as defined in Exchange Act Rules <FONT
STYLE="white-space:nowrap">13a-15</FONT> and <FONT STYLE="white-space:nowrap">15d-15)</FONT> that are designed to ensure that material information relating to the Company and its subsidiaries is made known to the certifying officers by others within
those entities, particularly during the period in which the Company&#146;s Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> or Quarterly Report on Form <FONT STYLE="white-space:nowrap">10-Q,</FONT> as the case may be, is being
prepared. The Company&#146;s certifying officers have evaluated the effectiveness of the Company&#146;s controls and procedures as of the end of the period covered by the Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the
year ended March&nbsp;31, 2023 (such date, the &#147;<B>Evaluation Date</B>&#148;). The Company presented in its Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the year ended March&nbsp;31, 2023 the conclusions of the
certifying officers about the effectiveness of the disclosure controls and procedures based on their evaluations as of the Evaluation Date. Since the Evaluation Date, there have been no significant changes in the Company&#146;s internal control over
financial reporting (as defined under Exchange Act Rules <FONT STYLE="white-space:nowrap">13a-15</FONT> and <FONT STYLE="white-space:nowrap">15d-15)</FONT> or, to the Company&#146;s knowledge, in other factors that could significantly affect the
Company&#146;s internal controls (other than as set forth in the Registration Statement, the General Disclosure Package and the Prospectus). To the knowledge of the Company, the Company&#146;s &#147;internal controls over financial reporting&#148;
and &#147;disclosure controls and procedures&#148; are effective. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(ff) <U>Sarbanes-Oxley Act.</U> There is and has been no failure on the part of the
Company or, to the knowledge of the Company, any of the Company&#146;s directors or officers, in their capacities as such, to comply in all material respects with any applicable provisions of the Sarbanes-Oxley Act and the rules and regulations
promulgated thereunder. Each of the principal executive officer and the principal financial officer of the Company (or each former principal executive officer of the Company and each former principal financial officer of the Company as applicable)
has made all certifications required by Sections 302 and 906 of the Sarbanes-Oxley Act with respect to all reports, schedules, forms, statements and other documents required to be filed by it or furnished by it to the Commission during the past 12
months. For purposes of the preceding sentence, &#147;principal executive officer&#148; and &#147;principal financial officer&#148; shall have the meanings given to such terms in the Exchange Act Rules <FONT STYLE="white-space:nowrap">13a-15</FONT>
and <FONT STYLE="white-space:nowrap">15d-15.</FONT> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(gg) <U>Minute Books</U>. The minute books of the Company have been made available to the Underwriters and
counsel for the Underwriters, and such books (i)&nbsp;contain a complete summary of all meetings and actions of the board of directors (including each board committee) and stockholders of the Company (or analogous governing bodies and interest
holders, as applicable), since October&nbsp;26, 2020 through the date of the latest meeting and action, and (ii)&nbsp;accurately in all material respects reflect all transactions referred to in such minutes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(hh) <U>Statistical and Market Data</U>. The statistical and market related data included in the Registration Statement, the General Disclosure Package and
the Prospectus are based on or derived from sources that the Company believes to be reliable and accurate in all material respects. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(ii) <U>Broker&#146;s
Fees.</U> Except pursuant to this Agreement, neither the Company nor any of its subsidiaries is a party to any contract, agreement or understanding with any person that would give rise to a valid claim against the Company or any of its subsidiaries
or the Underwriters for a brokerage commission, finder&#146;s fee or like payment in connection with the offering and sale of the Stock or any transaction contemplated by this Agreement, or the Registration Statement, the General Disclosure Package
or the Prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(jj) <U>Listing</U>. The Company is subject to and in compliance in all material respects with the reporting requirements of
Section&nbsp;13 or Section&nbsp;15(d) of the Exchange Act. The Common Stock is registered pursuant to Section&nbsp;12(b) or 12(g) of the Exchange Act and is listed on The Nasdaq Global Select Market, and the Company has taken no action designed to,
or reasonably likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from The Nasdaq Global Select Market, nor has the Company received any written notification that the
Commission or FINRA is contemplating terminating such registration or listing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(kk) <U>Labor Disputes.</U> No labor disturbance by or dispute with
employees of the Company or any Subsidiary exists or, to the knowledge of the Company, is threatened which would reasonably be expected to result in a Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(ll) <U>Investment Company Act.</U> Neither the Company nor any Subsidiary is or, after giving effect to the offering of the Stock and the application of the
proceeds thereof as described in the General Disclosure Package and the Prospectus, will be an &#147;investment company&#148; or an entity &#147;controlled&#148; by an &#147;investment company,&#148; as such terms are defined in the Investment
Company Act of 1940, as amended. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(mm) <U>Operations.</U> The operations of the Company and the Subsidiaries are and have been conducted at all times in
compliance in all material respects with applicable financial record keeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended, the Bank Secrecy Act, as amended by Title III of the Uniting and
Strengthening America by Providing Appropriate Tools Required to Intercept and Obstruct Terrorism Act of 2001 (&#147;<B>USA PATRIOT Act</B>&#148;), and the money laundering statutes of all jurisdictions to which the Company or the Subsidiaries are
subject, the rules and regulations thereunder and any related or similar rules, regulations or guidelines, issued, administered or enforced by any governmental agency (collectively, the &#147;<B>Money Laundering Laws</B>&#148;), except as would not
reasonably be expected to result in a Material Adverse Effect; and no action, suit or proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company or any Subsidiary with respect to the Money
Laundering Laws is pending or, to the knowledge of the Company, threatened. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(nn) <U><FONT STYLE="white-space:nowrap">Off-Balance</FONT> Sheet
Arrangements.</U> There are no material <FONT STYLE="white-space:nowrap">off-balance</FONT> sheet arrangements (as defined in Item 303 of Regulation <FONT STYLE="white-space:nowrap">S-K)</FONT> that have or are reasonably likely to have a material
current or future effect on the Company&#146;s financial condition, results of operations, liquidity, capital expenditures or capital resources. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(oo)
<U>ERISA.</U> To the knowledge of the Company, each material employee benefit plan, within the meaning of Section&nbsp;3(3) of the Employee Retirement Income Security Act of 1974, as amended (&#147;<B>ERISA</B>&#148;), that is maintained,
administered or contributed to by the Company or any of its affiliates for employees or former employees of the Company and the Subsidiaries has been maintained in material compliance with its terms and the requirements of any applicable statutes,
orders, rules and regulations, including but not limited to ERISA and the Internal Revenue Code of 1986, as amended (the &#147;<B>Code</B>&#148;); no prohibited transaction, within the meaning of Section&nbsp;406 of ERISA or Section&nbsp;4975 of the
Code, has occurred which would result in a material liability to the Company with respect to any such plan excluding transactions effected pursuant to a statutory or administrative exemption; and for each such plan that is subject to the funding
rules of Section&nbsp;412 of the Code or Section&nbsp;302 of ERISA, no &#147;accumulated funding deficiency&#148; as defined in Section&nbsp;412 of the Code has been incurred, whether or not waived, and the fair market value of the assets of each
such plan (excluding for these purposes accrued but unpaid contributions) exceeds the present value of all benefits accrued under such plan determined using reasonable actuarial assumptions. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(pp) <U>Insurance.</U> The Company and the Subsidiaries carry, or are covered by, insurance in such amounts
and covering such risks as the Company and the Subsidiaries reasonably believe are adequate for the conduct of their business and as is customary for companies of similar size engaged in similar businesses in similar industries. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(qq) <U>No Improper Practices.</U> Neither the Company nor any of its subsidiaries, nor, to the Company&#146;s knowledge, any director, officer or employee of
the Company or any of its subsidiaries, nor, to the Company&#146;s knowledge, any director, officer, agent, employee, affiliate or other person associated with or acting on behalf of the Company or any of its subsidiaries has, directly or
indirectly, (i)&nbsp;used any corporate funds for unlawful contributions, gifts, entertainment or other unlawful expenses relating to political activity; (ii)&nbsp;made or taken an act in furtherance of an offer, promise or authorization of any
direct or indirect unlawful payment or benefit to any foreign or domestic government official or employee, including of any government-owned or controlled entity or of a public international organization, or any person acting in an official capacity
for or on behalf of any of the foregoing, or any political party or party official or candidate for political office; (iii)&nbsp;violated or is in violation of any anti-bribery laws, including but not limited to, any applicable law, rule or
regulation of any locality, including but not limited to any law, rule or regulation promulgated to implement the OECD Convention on Combating Bribery of Foreign Public Officials in International Business Transactions, signed December&nbsp;17, 1997,
including the U.S. Foreign Corrupt Practices Act of 1977, as amended, the U.K. Bribery Act 2010, or any other applicable law, rule or regulation of similar purpose and scope or anti-corruption law; or (iv)&nbsp;made, offered, agreed, requested or
taken an act in furtherance of any unlawful bribe or other unlawful benefit, including, without limitation, any rebate, payoff, influence payment, kickback or other unlawful or improper payment or benefit. The Company and its subsidiaries have
instituted, maintained and enforced, and will continue to maintain and enforce, policies and procedures designed to promote and ensure compliance with all applicable anti-bribery and anti-corruption laws. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(rr) <U>No Conflicts.</U> Neither the execution of this Agreement, nor the issuance and sale of the Stock by the Company, nor the consummation of any of the
transactions contemplated hereby and thereby, nor the compliance by the Company with the terms and provisions hereof and thereof will conflict with, or will result in a breach of, any of the terms and provisions of, or has constituted or will
constitute a default under, or has resulted in or will result in the creation or imposition of any lien, charge or encumbrance upon any property or assets of the Company pursuant to the terms of any contract or other agreement to which the Company
may be bound or to which any of the property or assets of the Company is subject, except (i)&nbsp;such conflicts, breaches or defaults as may have been waived and (ii)&nbsp;such conflicts, breaches and defaults that would not reasonably be expected
to have a Material Adverse Effect; nor will such action result (x)&nbsp;in any violation of the provisions of the organizational or governing documents of the Company, or (y)&nbsp;in any material violation of the provisions of any statute or any
order, rule or regulation applicable to the Company or of any court or of any federal, state or other regulatory authority or other government body having jurisdiction over the Company, except where such violation would not reasonably be expected to
have a Material Adverse Effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(ss) <U>OFAC</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(i) The Company represents that, neither the Company nor any Subsidiary (collectively, the &#147;<B>Entity</B>&#148;) or to the Company&#146;s
knowledge any director, officer, employee, agent, affiliate or representative of the Entity, is a government, individual, or entity (in this paragraph (tt), &#147;<B>Person</B>&#148;) that is, or is owned or controlled by a Person that is: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">(a) the subject of any sanctions administered or enforced by the U.S. Department of Treasury&#146;s Office of Foreign Assets Control
(&#147;<B>OFAC</B>&#148;), the United Nations Security Council, the European Union, Her Majesty&#146;s Treasury, or other relevant sanctions authority (collectively, &#147;<B>Sanctions</B>&#148;), nor </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">(b) located, organized or resident in a country or territory that is the subject of Sanctions (including, without limitation, the <FONT
STYLE="white-space:nowrap">so-called</FONT> Donetsk People&#146;s Republic, the <FONT STYLE="white-space:nowrap">so-called</FONT> Luhansk People&#146;s Republic or any other Covered Region of Ukraine identified pursuant to Executive Order 14065, the
Crimea region of Ukraine, Cuba, Iran, North Korea and Syria). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(ii) The Entity represents and covenants that it will not, directly or
indirectly, knowingly use the proceeds of the offering, or knowingly lend, contribute or otherwise make available such proceeds to any subsidiary, joint venture partner or other Person: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">(a) to fund or facilitate any activities or business of or with any Person or in any country or territory that, at the time of such funding or
facilitation, is the subject of Sanctions; or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">(b) in any other manner that will result in a violation of Sanctions by any Person
(including any Person participating in the offering, whether as underwriter, advisor, investor or otherwise). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(iii) The Entity represents
and covenants that, except as detailed in the Prospectus, for the past 5 years, it has not knowingly engaged in, is not now knowingly engaged in, and will not engage in, any dealings or transactions with any Person, or in any country or territory,
that at the time of the dealing or transaction that constituted a violation of Sanctions. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(iv) The Entity represents that it has implemented and maintains in effect policies and
procedures designed to ensure compliance by the Entity, and the Entity, and to the knowledge of the Company, any Persons, are in compliance with all applicable Sanctions, and are not knowingly engaged in any activity that would reasonably be
expected to result in the Entity being designated as the subject or target of Sanctions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(tt) <U>Data Privacy and Cybersecurity</U>. (i)(x) To the
knowledge of Company, there has been no security breach, destruction, loss, unauthorized distribution, use, access, disablement, misappropriation or modification, or other compromise or misuse (&#147;<B>Breach</B>&#148;) of any Personal Data (as
defined herein) and/or any of the Company&#146;s information technology and computer systems, networks, hardware, software used to store, collect, use, transfer, import, export, protect and/or process any Personal Data (collectively, &#147;<B>IT
Systems and Data</B>&#148;) and (y)&nbsp;the Company has not been notified of, and has no knowledge of any event or condition that would reasonably be expected to result in, any material Breach to their IT Systems and Data; (ii)&nbsp;the Company is
presently in compliance with all applicable laws or statutes and all applicable judgments, orders, rules and regulations of any court or arbitrator or governmental or regulatory authority, internal policies and contractual obligations relating to
the privacy and security of IT Systems and Data and to the protection of such IT Systems and Data from unauthorized use, access, misappropriation or modification, if any, except as would not, in the case of this clause (ii), individually or in the
aggregate, have a Material Adverse Effect; and (iii)&nbsp;the Company has not, and has not been required to notify in writing, any person or entity of any IT Systems and Data or information security-related incident under any applicable law,
regulation or contract. &#147;<B>Personal Data</B>&#148; means (i)&nbsp;a natural person&#146;s name, street address, telephone number, email address, photograph, social security number, bank information, or customer or account number; (ii)&nbsp;any
information which would qualify as &#147;personally identifying information&#148; under the Federal Trade Commission Act, as amended; (iii)&nbsp;Protected Health Information as defined by Health Insurance Portability and Accountability Act, as
amended; and (iv)&nbsp;any other piece of information that identifies such natural person, or his or her family, or identifies a specific person&#146;s health condition or sexual orientation. The Company and each of the Subsidiaries have taken
reasonable technical and organizational measures designed to protect the confidentiality, integrity and availability of information technology systems and IT Systems and Data used in connection with the operation of the Company&#146;s and its
Subsidiaries&#146; businesses. Without limiting the foregoing, the Company and its Subsidiaries have used reasonable efforts to establish and maintain, and have established, maintained, implemented and complied with, reasonable information
technology, information security, cyber security and data protection controls, policies and procedures, including oversight, access controls, encryption, technological and physical safeguards and business continuity/disaster recovery and security
plans that are designed to protect against and prevent any Breach. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(uu) <U>No Integration</U>. Except as described in the Registration Statement, the
General Disclosure Package and the Prospectus, the Company has not sold or issued any shares of Common Stock during the <FONT STYLE="white-space:nowrap">six-month</FONT> period preceding the date of the Prospectus, including any sales pursuant to
Rule 144A under, or Regulations D or S of, the Securities Act, other than shares issued pursuant to employee benefit plans, qualified stock options plans or other employee compensation plans or pursuant to outstanding options, rights or warrants.
For the avoidance of doubt, the Company has not sold or issued any securities that would be integrated with the offering of the Stock contemplated by this Agreement pursuant to the Securities Act, the Rules and Regulations or any interpretations
thereof by the Commission. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(vv) <U>Forward-Looking Statements</U>. No forward-looking statement (within the meaning of Section&nbsp;27A of the Securities
Act and Section&nbsp;21E of the Exchange Act) contained in the Registration Statement, the General Disclosure Package or the Prospectus has been made or reaffirmed without a reasonable basis or has been disclosed other than in good faith. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Any certificate signed by or on behalf of the Company and delivered to the Representative or to counsel for the Underwriters shall be deemed to be a
representation and warranty by the Company to each Underwriter as to the matters covered thereby. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">3. <I>PURCHASE, SALE AND DELIVERY OF OFFERED
SECURITIES</I>. On the basis of the representations, warranties and agreements herein contained, but subject to the terms and conditions herein set forth, the Company agrees to sell to the Underwriters, and the Underwriters agree, severally and not
jointly, to purchase from the Company the respective numbers of shares of Firm Stock set forth opposite the names of the Underwriters in <U>Schedule A</U> hereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The purchase price per share to be paid by the Underwriters to the Company for the Stock will be $10.575 per share (the &#147;<B>Purchase Price</B>&#148;).
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company will deliver the Firm Stock to the Representative for the respective accounts of the several Underwriters, through the facilities of The
Depository Trust Company, in each such case, issued in such names and in such denominations as the Representative may direct by notice in writing to the Company given at or prior to 12:00 Noon, New York time, on the second (2<SUP
STYLE="font-size:75%; vertical-align:top">nd</SUP>) full business day preceding the Closing Date against payment of the aggregate Purchase Price therefor by wire transfer in federal (same day) funds to an account at a bank specified by the Company
payable to the order of the Company for the Firm Stock sold by them. Time shall be of the essence, and delivery at the time and place specified pursuant to this </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Agreement is a further condition of the obligations of each Underwriter hereunder. The time and date of the delivery and closing shall be at 10:00 A.M., New York time, on February&nbsp;2, 2024,
in accordance with Rule <FONT STYLE="white-space:nowrap">15c6-1</FONT> of the Exchange Act. The time and date of such payment and delivery are herein referred to as the &#147;<B>Closing Date</B>.&#148; The Closing Date and the location of delivery
of, and the form of payment for, the Firm Stock may be varied by agreement between the Company and the Representative. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Underwriters may purchase all
or less than all of the Optional Stock. The price per share to be paid for the Optional Stock shall be the Purchase Price. The Company agrees to sell to the Underwriters the number of shares of Optional Stock specified in the written notice
delivered by the Representative to the Company described below and the Underwriters agree, severally and not jointly, to purchase such shares of Optional Stock. Such shares of Optional Stock shall be purchased from the Company for the account of
each Underwriter in the same proportion as the number of shares of Firm Stock set forth opposite such Underwriter&#146;s name on <U>Schedule A</U> bears to the total number of shares of Firm Stock (subject to adjustment by the Representative to
eliminate fractions). The option granted hereby may be exercised as to all or any part of the Optional Stock at any time, and from time to time, <I>provided</I> <I>however</I>, that notice of such exercise must be delivered not more than thirty
(30)&nbsp;days subsequent to the date of this Agreement. No Optional Stock shall be sold and delivered unless the Firm Stock previously has been, or simultaneously is, sold and delivered. The right to purchase the Optional Stock or any portion
thereof may be surrendered and terminated at any time upon notice by the Representative to the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The option granted hereby may only be exercised
by the Representative by providing the Company written notice setting forth the number of shares of the Optional Stock to be purchased by the Underwriters and the date and time for delivery of and payment for the Optional Stock. Each date and time
for delivery of and payment for the Optional Stock (which may be the Closing Date, but not earlier) is herein called the &#147;<B>Option Closing Date</B>&#148; and shall in no event be earlier than two (2)&nbsp;business days nor later than five
(5)&nbsp;business days after written notice is given. The Option Closing Date and the Closing Date are herein called the &#147;<B>Closing Dates</B>.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company will deliver the Optional Stock to the Representative for the respective accounts of the several Underwriters through the facilities of The
Depository Trust Company issued in such names and in such denominations as the Representative may direct by notice in writing to the Company given at or prior to 12:00 Noon, New York time, on the second (2<SUP
STYLE="font-size:75%; vertical-align:top">nd</SUP>) full business day preceding the Option Closing Date against payment of the aggregate Purchase Price therefor by wire transfer in federal (same day) funds to an account at a bank acceptable to the
Representative payable to the order of the Company. Time shall be of the essence, and delivery at the time and place specified pursuant to this Agreement is a further condition of the obligations of each Underwriter hereunder. The Option Closing
Date and the location of delivery of, and the form of payment for, the Optional Stock may be varied by agreement between the Company and the Representative. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The several Underwriters propose to offer the Stock for sale upon the terms and conditions set forth in the Prospectus. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">4. <I>FURTHER AGREEMENTS OF THE COMPANY</I>. The Company agrees with the several Underwriters: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(a) <U>Required Filings; Amendments or Supplements; Notice to the Representative</U>. To prepare the Rule 462(b) Registration Statement, if necessary, in a
form approved by the Representative and file such Rule 462(b) Registration Statement with the Commission before 10:00 P.M., New York time, on the date hereof, and the Company shall at the time of filing either pay to the Commission the filing fee
for the Rule 462(b) Registration Statement or give irrevocable instructions for the payment of such fee pursuant to Rule 111 under the Rules and Regulations; to prepare the Prospectus in a form approved by the Representative containing information
previously omitted at the time of effectiveness of the Registration Statement in reliance on Rules 430A, 430B or 430C of the Rules and Regulations and to file such Prospectus pursuant to Rule 424(b) of the Rules and Regulations not later than the
second (2<SUP STYLE="font-size:75%; vertical-align:top">nd</SUP>) business day following the execution and delivery of this Agreement or, if applicable, such earlier time as may be required by the Securities Act; to notify the Representative
immediately of the Company&#146;s intention to file or prepare any supplement or amendment to the Registration Statement or to the Prospectus and to make no amendment or supplement to the Registration Statement, the General Disclosure Package or to
the Prospectus to which the Representative shall reasonably object by notice to the Company after a reasonable period to review; to advise the Representative, promptly after it receives notice thereof, of the time when any amendment to the
Registration Statement has been filed or becomes effective or any supplement to the General Disclosure Package or the Prospectus or any amended Prospectus or any Issuer Free Writing Prospectus has been filed and to furnish the Underwriters with
copies thereof; to file promptly all material required to be filed by the Company with the Commission pursuant to Rules 433(d) or 163(b)(2) of the Rules and Regulations, as the case may be; to file promptly all reports and any definitive proxy or
information statements required to be filed by the Company with the Commission pursuant to Section&nbsp;13(a), 13(c), 14 or 15(d) of the Exchange Act subsequent to the date of the Prospectus and for so long as the delivery of a prospectus (or in
lieu thereof, the notice referred to in Rule 173(a) of the Rules and Regulations) is required in connection with the offering or sale of the Stock; to advise the Representative, promptly after it receives notice thereof, of the issuance by the
Commission of any stop order or of any order </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
preventing or suspending the use of any Preliminary Prospectus, any Issuer Free Writing Prospectus, or the Prospectus, of the suspension of the qualification of the Stock for offering or sale in
any jurisdiction, of the initiation or threatening of any proceeding for any such purpose, or of any request by the Commission for the amending or supplementing of the Registration Statement, the General Disclosure Package or the Prospectus or for
additional information; and, in the event of the issuance of any stop order or of any order preventing or suspending the use of any Preliminary Prospectus, any Issuer Free Writing Prospectus or the Prospectus or suspending any such qualification,
and promptly to use its best efforts to obtain the withdrawal of such order. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(b) <U>Permitted Free Writing Prospectus</U>. The Company represents and
agrees that, unless it obtains the prior written consent of the Representative, and each Underwriter represents and agrees that, unless it obtains the prior written consent of the Company and the Representative, it has not made and will not make any
offer relating to the Stock that would constitute a &#147;free writing prospectus&#148; as defined in Rule 405 of the Rules and Regulations unless the prior written consent of the Representative has been received (each, a &#147;<B>Permitted Free
Writing Prospectus</B>&#148;); <I>provided</I> that the prior written consent of the Representative hereto shall be deemed to have been given in respect of the Issuer Free Writing Prospectuses included in <U>Schedule B</U> hereto. The Company
represents that it has treated and agrees that it will treat each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus, comply with the requirements of Rules 164 and 433 of the Rules and Regulations applicable to any Issuer Free
Writing Prospectus, including the requirements relating to timely filing with the Commission, legending and record keeping and will not take any action that would result in an Underwriter or the Company being required to file with the Commission
pursuant to Rule 433(d) of the Rules and Regulations a free writing prospectus prepared by or on behalf of such Underwriter that such Underwriter otherwise would not have been required to file thereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(c) <U>Ongoing Compliance</U>. If at any time prior to the date when a prospectus relating to the Stock is required to be delivered (or in lieu thereof, the
notice referred to in Rule 173(a) under the Securities Act) any event occurs or condition exists as a result of which the Prospectus as then amended or supplemented would include any untrue statement of a material fact, or omit to state any material
fact necessary to make the statements therein, in the light of the circumstances under which they were made when the Prospectus is delivered (or in lieu thereof, the notice referred to in Rule 173(a) of the Rules and Regulations), not misleading, or
if it is necessary at any time to amend or supplement the Registration Statement or the Prospectus or to file under the Exchange Act any document incorporated by reference in the Prospectus to comply with the Securities Act or the Exchange Act, that
the Company will promptly notify the Representative thereof and upon their request will prepare an appropriate amendment or supplement or upon their request make an appropriate filing pursuant to Section&nbsp;13 or 14 of the Exchange Act in form and
substance satisfactory to the Representative which will correct such statement or omission or effect such compliance and will use its reasonable best efforts to have any amendment to the Registration Statement declared effective as soon as possible.
The Company will furnish without charge to each Underwriter and to any dealer in securities as many copies as the Representative may from time to time reasonably request of such amendment or supplement. In case any Underwriter is required to deliver
a prospectus (or in lieu thereof, the notice referred to in Rule 173(a) of the Rules and Regulations) relating to the Stock, the Company upon the request of the Representative will prepare promptly an amended or supplemented Prospectus as may be
necessary to permit compliance with the requirements of Section&nbsp;10(a)(3) of the Securities Act and deliver to such Underwriter as many copies as such Underwriter may request of such amended or supplemented Prospectus complying with
Section&nbsp;10(a)(3) of the Securities Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(d) <U>Amendment to General Disclosure Package</U>. If the General Disclosure Package is being used to
solicit offers to buy the Stock at a time when the Prospectus is not yet available to prospective purchasers and any event shall occur as a result of which, in the judgment of the Company or in the reasonable opinion of the Underwriters, it becomes
necessary to amend or supplement the General Disclosure Package in order to make the statements therein, in the light of the circumstances then prevailing, not misleading, or to make the statements therein not conflict with the information contained
or incorporated by reference in the Registration Statement then on file and not superseded or modified, or if it is necessary at any time to amend or supplement the General Disclosure Package to comply with any law, the Company promptly will either
(i)&nbsp;prepare, file with the Commission (if required) and furnish to the Underwriters and any dealers an appropriate amendment or supplement to the General Disclosure Package or (ii)&nbsp;prepare and file with the Commission an appropriate filing
under the Exchange Act which shall be incorporated by reference in the General Disclosure Package so that the General Disclosure Package as so amended or supplemented will not, in the light of the circumstances then prevailing, be misleading or
conflict with the Registration Statement then on file, or so that the General Disclosure Package will comply with law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(e) <U>Amendment to Issuer Free
Writing Prospectus</U>. If at any time following issuance of an Issuer Free Writing Prospectus there occurred or occurs an event or development as a result of which such Issuer Free Writing Prospectus conflicted or will conflict with the information
contained in the Registration Statement, Pricing Prospectus or Prospectus, including any document incorporated by reference therein and any prospectus supplement deemed to be a part thereof and not superseded or modified or included or would include
an untrue statement of a material fact or omitted or would omit to state a material fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances prevailing at the subsequent time, not
misleading, the Company has promptly notified or will promptly notify the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Representative so that any use of the Issuer Free Writing Prospectus may cease until it is amended or supplemented and has promptly amended or will promptly amend or supplement, at its own
expense, such Issuer Free Writing Prospectus to eliminate or correct such conflict, untrue statement or omission. The foregoing sentence does not apply to statements in or omissions from any Issuer Free Writing Prospectus in reliance upon, and in
conformity with, written information furnished to the Company through the Representative by or on behalf of any Underwriter specifically for inclusion therein, which information the parties hereto agree is limited to the Underwriters&#146;
Information. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(f) <U>Delivery of Registration Statement</U>. To the extent not available on the Commission&#146;s Electronic Data Gathering, Analysis and
Retrieval system or any successor system (&#147;<B>EDGAR</B>&#148;), upon the request of the Representative, to furnish promptly to the Representative and to counsel for the Underwriters a signed copy of the Registration Statement as originally
filed with the Commission, and of each amendment thereto filed with the Commission, including all consents and exhibits filed therewith. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(g) <U>Delivery
of Copies</U>. Upon request of the Representative, to the extent not available on EDGAR, to deliver promptly to the Representative in New York City such number of the following documents as the Representative shall reasonably request:
(i)&nbsp;conformed copies of the Registration Statement as originally filed with the Commission (in each case excluding exhibits), (ii) each Preliminary Prospectus, (iii)&nbsp;any Issuer Free Writing Prospectus, (iv)&nbsp;the Prospectus (the
delivery of the documents referred to in clauses (i), (ii), (iii) and (iv)&nbsp;of this paragraph (g)&nbsp;to be made not later than 10:00 A.M., New York time, on the business day following the execution and delivery of this Agreement), (v)
conformed copies of any amendment to the Registration Statement (excluding exhibits), (vi) any amendment or supplement to the General Disclosure Package or the Prospectus (the delivery of the documents referred to in clauses (v)&nbsp;and (vi) of
this paragraph (g)&nbsp;to be made not later than 10:00 A.M., New York City time, on the business day following the date of such amendment or supplement) and (vii)&nbsp;any document incorporated by reference in the General Disclosure Package or the
Prospectus (excluding exhibits thereto) (the delivery of the documents referred to in clause (vii)&nbsp;of this paragraph (g)&nbsp;to be made not later than 10:00 A.M., New York City time, on the business day following the date of such document).
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(h) <U>Earnings Statement</U>. To make generally available to its stockholders as soon as practicable, but in any event not later than sixteen
(16)&nbsp;months after the effective date of the Registration Statement (as defined in Rule 158(c) of the Rules and Regulations), an earnings statement of the Company and its subsidiaries (which need not be audited) complying with Section&nbsp;11(a)
of the Securities Act (including, at the option of the Company, Rule 158). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(i) <U>Blue Sky Compliance</U>. To take promptly from time to time such
actions as the Representative may reasonably request to qualify the Stock for offering and sale under the securities or Blue Sky laws of such jurisdictions (domestic or foreign) as the Representative may reasonably designate and to continue such
qualifications in effect, and to comply with such laws, for so long as required to permit the offer and sale of Stock in such jurisdictions; <I>provided</I> that the Company and its subsidiaries shall not be obligated to (i)&nbsp;qualify as foreign
corporations in any jurisdiction in which they are not so qualified, (ii)&nbsp;file a general consent to service of process in any jurisdiction or (iii)&nbsp;subject itself to taxation in any such jurisdiction if it is not otherwise so subject. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(j) <U>Reports</U>. Upon request, during the period of five (5)&nbsp;years from the date hereof, to deliver to each of the Underwriters, (i)&nbsp;as soon as
they are available, copies of all reports or other communications (financial or other) furnished to stockholders, and (ii)&nbsp;as soon as they are available, copies of any reports and financial statements furnished or filed with the Commission or
any national securities exchange on which the Common Stock is listed. However, so long as the Company is subject to the reporting requirements of either Section&nbsp;13 or Section&nbsp;15(d) of the Exchange Act and is timely filing reports EDGAR, it
is not required to furnish such reports or statements to the Underwriters. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(k) <U><FONT STYLE="white-space:nowrap">Lock-Up</FONT></U>. During the period
commencing on and including the date hereof and ending on and including the 90<SUP STYLE="font-size:75%; vertical-align:top">th</SUP> day following the date of this Agreement (as the same may be extended as described below, the &#147;<B><FONT
STYLE="white-space:nowrap">Lock-Up</FONT> Period</B>&#148;) the Company will not, without the prior written consent of the Representative (which consent may be withheld at the sole discretion of the Representative), directly or indirectly offer,
sell (including, without limitation, any short sale), assign, transfer, pledge, contract to sell, establish an open &#147;put equivalent position&#148; within the meaning of Rule <FONT STYLE="white-space:nowrap">16a-1(h)</FONT> under the Exchange
Act, or otherwise dispose of, or announce the offering of, or file any registration statement under the Securities Act in respect of, any Common Stock, options, rights or warrants to acquire Common Stock or securities exchangeable or exercisable for
or convertible into Common Stock (other than is contemplated by this Agreement with respect to the Stock), or publicly announce any intention to do any of the foregoing; <I>provided, however</I>, that the Company may (i)&nbsp;issue Common Stock and
options to purchase Common Stock, shares of Common Stock underlying options granted and other securities, each pursuant to any director or employee benefits plan, stock incentive plan, stock ownership plan or dividend reinvestment plan of the
Company in effect on the date hereof and described in the General Disclosure Package; (ii)&nbsp;issue Common Stock pursuant to the conversion of securities or the exercise of warrants, which securities or warrants are outstanding on the date hereof
and described in the Registration Statement, the General Disclosure Package and the Prospectus; (iii)&nbsp;adopt a new equity incentive plan, and file a registration statement on Form <FONT STYLE="white-space:nowrap">S-8</FONT> under the Securities
Act to register the offer and sale of securities to be issued pursuant to such new equity incentive plan, and issue securities pursuant to such new equity incentive plan (including, without limitation, the issuance of shares of Common Stock upon the
exercise of options or other securities </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
issued pursuant to such new equity incentive plan), provided that (1)&nbsp;such new equity incentive plan satisfies the transaction requirements of General Instruction A.1 of Form <FONT
STYLE="white-space:nowrap">S-8</FONT> under the Securities Act and (2)&nbsp;this clause (iii)&nbsp;shall not be available unless each recipient of shares of Common Stock, or securities exchangeable or exercisable for or convertible into Common
Stock, pursuant to such new equity incentive plan shall be contractually prohibited from selling, offering, disposing of or otherwise transferring any such shares or securities during the remainder of the
<FONT STYLE="white-space:nowrap">Lock-Up</FONT> Period; and (iv)&nbsp;issue shares of Common Stock, or securities exchangeable or exercisable for or convertible into Common Stock, in connection with a transaction with an unaffiliated third party on
an <FONT STYLE="white-space:nowrap">arm&#146;s-length</FONT> basis that includes a <I>bona fide </I>commercial relationship (including joint ventures, marketing or distribution arrangements, collaboration agreements or intellectual property license
agreements) or any acquisition of assets or not less than a majority or controlling portion of the equity of another entity, provided that the aggregate number of shares issued pursuant to this clause (iv)&nbsp;shall not exceed ten percent (10%) of
the total number of outstanding shares of Common Stock immediately following the issuance and sale of the Firm Stock pursuant hereto. In addition, the Company will cause each person and entity listed in <U>Schedule D</U> to furnish to the
Representative, prior to the Closing Date, a letter, substantially in the form of <U>Exhibit A</U> hereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(l) <U>Delivery of SEC Correspondence</U>. To
supply the Underwriters with copies of all correspondence to and from, and all documents issued to and by, the Commission in connection with the registration of the Stock under the Securities Act or any of the Registration Statement, any Preliminary
Prospectus or the Prospectus, or any amendment or supplement thereto or document incorporated by reference therein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(m) <U>Press Releases</U>. Prior to
the Closing Date, not to issue any press release or other communication directly or indirectly or hold any press conference with respect to the Company, its condition, financial or otherwise, or earnings, business affairs or business prospects
(except for routine oral marketing communications in the ordinary course of business and consistent with the past practices of the Company and of which the Representative is notified), without the prior consent of the Representative, unless in the
judgment of the Company and its counsel, and after notification to the Representative, such press release or communication is required by law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(n)
<U>Compliance with Regulation M</U>. Until the Underwriters shall have notified the Company of the completion of the resale of the Stock, that the Company will not, and will use its reasonable best efforts to cause its affiliated purchasers (as
defined in Regulation M under the Exchange Act) not to, either alone or with one or more other persons, bid for or purchase, for any account in which it or any of its affiliated purchasers has a beneficial interest, any Stock, or attempt to induce
any person to purchase any Stock; and not to, and to use its reasonable best efforts to cause its affiliated purchasers not to, make bids or purchase for the purpose of creating actual, or apparent, active trading in or of raising the price of the
Stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(o) <U>Registrar and Transfer Agent</U>. To maintain, at its expense, a registrar and transfer agent for the Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(p) <U>Use of Proceeds</U>. To apply the net proceeds from the sale of the Stock as set forth in the Registration Statement, the General Disclosure Package
and the Prospectus under the heading &#147;Use of Proceeds,&#148; and except as disclosed in the General Disclosure Package and the Prospectus, the Company does not intend to use any of the proceeds from the sale of the Stock hereunder to repay any
outstanding debt owed to any affiliate of any Underwriter. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(q) <U>Exchange Listing</U><I>.</I> To use its reasonable best efforts to list for quotation
the Stock on The Nasdaq Global Select Market. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(r) <U>Performance of Covenants and Satisfaction of Conditions</U>. To use its reasonable best efforts to
do and perform all things required to be done or performed under this Agreement by the Company prior to each Closing Date and to satisfy all conditions precedent to the delivery of the Firm Stock and the Optional Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(s) <U>Shelf Renewal</U>. If immediately prior to the third anniversary (the &#147;<B>Renewal Deadline</B>&#148;) of the initial effective date of the
Registration Statement, any of the Stock remains unsold by the Underwriters, the Company will, prior to the Renewal Deadline, file, if it has not already done so and is eligible to do so, a new automatic shelf registration statement relating to the
Stock, in a form satisfactory to the Representative. If the Company is not eligible to file an automatic shelf registration statement, the Company will, prior to the Renewal Deadline, if it has not already done so, file a new shelf registration
statement relating to the Stock, in a form satisfactory to the Representative, and will use its best efforts to cause such registration statement to be declared effective within 180 days after the Renewal Deadline. The Company will take all other
action necessary or appropriate to permit the issuance and sale of the Stock to continue as contemplated in the expired registration statement relating to the Stock. References herein to the Registration Statement shall include such new automatic
shelf registration statement or such new shelf registration statement, or any post-effective amendment thereto, as the case may be. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5. <I>PAYMENT OF
EXPENSES</I>. The Company agrees to pay, or reimburse if paid by any Underwriter, whether or not the transactions contemplated hereby are consummated or this Agreement is terminated: (a)&nbsp;the costs incident to the authorization, issuance, sale,
preparation and delivery of the Stock and any taxes payable in that connection; (b)&nbsp;the costs incident to the registration of the Stock under the Securities Act; (c)&nbsp;the costs incident to the preparation, printing and distribution of the
Registration Statement, the Base Prospectus, any Preliminary Prospectus, any Issuer Free Writing </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Prospectus, the General Disclosure Package, the Prospectus, any amendments, supplements and exhibits thereto or any document incorporated by reference therein and the costs of printing,
reproducing and distributing the &#147;Agreement Among Underwriters&#148; between the Representative and the Underwriters, the Master Selected Dealers&#146; Agreement, the Underwriters&#146; Questionnaire, this Agreement and any closing documents by
mail, telex or other means of communications; (d)&nbsp;the reasonable and documented fees and expenses (including related fees and expenses of counsel for the Underwriters up to $5,000) incurred in connection with securing any required review by
FINRA of the terms of the sale of the Stock and any filings made with FINRA; (e)&nbsp;any applicable listing or other fees; (f)&nbsp;the fees and expenses (including related fees and expenses of counsel to the Underwriters) of qualifying the Stock
under the securities laws of the several jurisdictions as provided in Section&nbsp;4(i)) and of preparing, printing and distributing wrappers, Blue Sky Memoranda and Legal Investment Surveys; (g)&nbsp;the cost of preparing and printing stock
certificates; (h)&nbsp;all fees and expenses of the registrar and transfer agent of the Common Stock; (i)&nbsp;the fees, disbursements and expenses of counsel to the Underwriters; (j)&nbsp;the costs and expenses of the Company relating to investor
presentations on any &#147;road show&#148; undertaken in connection with the marketing of the offering of the Stock, including, without limitation, expenses associated with the preparation or dissemination of any electronic road show, expenses
associated with the production of road show slides and graphics, fees and expenses of any consultants engaged in connection with the road show presentations with the prior approval of the Company, and the travel and lodging expenses of the officers
of the Company and such consultants, including the cost of any aircraft chartered in connection with the road show; and (k)&nbsp;all other costs and expenses incident to the offering of the Stock or the performance of the obligations of the Company
under this Agreement (including, without limitation, the fees and expenses of the Company&#146;s counsel and the Company&#146;s independent accountants); <I>provided</I> that, except to the extent otherwise provided in this Section&nbsp;5 and in
Sections 9 and 10, the Underwriters shall pay their own costs and expenses, including the fees and expenses of their counsel not contemplated herein, any transfer taxes on the resale of any Stock by them and the expenses of advertising any offering
of the Stock made by the Underwriters; and <I>provided further</I>, that the fees and disbursements of counsel and other costs and expenses of the Underwriters payable by the Company pursuant to this Section&nbsp;5 and Sections 9 and 10 shall not
exceed $75,000 in the aggregate. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">6. <I>CONDITIONS OF UNDERWRITERS&#146; OBLIGATIONS.</I> The obligations of the Underwriters under this Agreement are
several and not joint. The respective obligations of the several Underwriters hereunder are subject to the accuracy, when made and as of the Applicable Time and on each Closing Date, of the representations and warranties of the Company contained
herein, to the accuracy of the statements of the Company made in any certificates pursuant to the provisions hereof, to the performance by the Company of its obligations hereunder, and to each of the following additional terms and conditions: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(a) <U>Registration Compliance; No Stop Orders</U>. The Registration Statement has become effective under the Securities Act, and no stop order suspending the
effectiveness of the Registration Statement or any part thereof, preventing or suspending the use of any Base Prospectus, Preliminary Prospectus, the Prospectus or any Permitted Free Writing Prospectus or any part thereof shall have been issued and
no proceedings for that purpose or pursuant to Section&nbsp;8A under the Securities Act shall have been initiated or, to the knowledge of the Company, threatened by the Commission, and all requests for additional information on the part of the
Commission (to be included or incorporated by reference in the Registration Statement or the Prospectus or otherwise) shall have been complied with to the reasonable satisfaction of the Representative; the Rule 462(b) Registration Statement, if any,
each Issuer Free Writing Prospectus and the Prospectus shall have been filed with, the Commission within the applicable time period prescribed for such filing by, and in compliance with, the Rules and Regulations and in accordance with
Section&nbsp;4(a), and the Rule 462(b) Registration Statement, if any, shall have become effective immediately upon its filing with the Commission; and FINRA shall have raised no unresolved objection to the fairness and reasonableness of the terms
of this Agreement or the transactions contemplated hereby. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(b) <U>No Material Misstatements</U>. None of the Underwriters shall have discovered and
disclosed to the Company on or prior to each Closing Date that the Registration Statement or any amendment or supplement thereto contains an untrue statement of a fact which, in the opinion of counsel for the Underwriters, is material or omits to
state any fact which, in the opinion of such counsel, is material and is required to be stated therein or is necessary to make the statements therein not misleading, or that the General Disclosure Package, any Issuer Free Writing Prospectus or the
Prospectus or any amendment or supplement thereto contains an untrue statement of fact which, in the opinion of such counsel, is material or omits to state any fact which, in the opinion of such counsel, is material and is necessary in order to make
the statements, in the light of the circumstances in which they were made, not misleading. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(c) <U>Corporate Proceedings</U>. All corporate proceedings
incident to the authorization, form and validity of each of this Agreement, the Stock, the Registration Statement, the General Disclosure Package, each Issuer Free Writing Prospectus and the Prospectus and the transactions contemplated hereby shall
be reasonably satisfactory in all material respects to counsel for the Underwriters, and the Company shall have furnished to such counsel all documents and information that they may reasonably request to enable them to pass upon such matters. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(d) <U>Opinion and <FONT STYLE="white-space:nowrap">10b-5</FONT> Statement of Counsel for the Company</U><I>. </I>Latham&nbsp;&amp; Watkins LLP shall have
furnished to the Representative such counsel&#146;s written opinion and <FONT STYLE="white-space:nowrap">10b-5</FONT> statement, as counsel to the Company, addressed to the Underwriters and dated each Closing Date, substantially in form and
substance satisfactory to the Representative. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(e) <U>Opinion and <FONT STYLE="white-space:nowrap">10b-5</FONT> Statement of Counsel for the
Underwriters.</U> The Representative shall have received from White&nbsp;&amp; Case LLP, counsel for the Underwriters, such opinion or opinions and <FONT STYLE="white-space:nowrap">10b-5</FONT> statement, dated each Closing Date, with respect to
such matters as the Underwriters may reasonably require, and the Company shall have furnished to such counsel such documents as they request for enabling them to pass upon such matters. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(f) <U>Comfort Letter</U>. At the time of the execution of this Agreement, the Representative shall have received from the Accountant a letter, addressed to
the Underwriters, executed and dated such date, in form and substance satisfactory to the Representative (i)&nbsp;confirming that they are an independent registered accounting firm with respect to the Company and its subsidiaries within the meaning
of the Securities Act and the Rules and Regulations and PCAOB and (ii)&nbsp;stating the conclusions and findings of such firm, of the type ordinarily included in accountants&#146; &#147;comfort letters&#148; to underwriters, with respect to the
financial statements and certain financial information contained or incorporated by reference in the Registration Statement, the General Disclosure Package and the Prospectus. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(g) <U>Bring-Down Comfort Letter</U>. On the effective date of any post-effective amendment to the Registration Statement and on each Closing Date, the
Representative shall have received a letter (the &#147;<B>bring-down letter</B>&#148;) from the Accountant addressed to the Underwriters and dated such Closing Date confirming, as of the date of the bring-down letter (or, with respect to matters
involving changes or developments since the respective dates as of which specified financial information is given in the General Disclosure Package and the Prospectus, as the case may be, as of a date not more than two (2)&nbsp;business days prior
to the date of the bring-down letter), the conclusions and findings of such firm, of the type ordinarily included in accountants&#146; &#147;comfort letters&#148; to underwriters, with respect to the financial information and other matters covered
by its letter delivered to the Representative concurrently with the execution of this Agreement pursuant to paragraph (f)&nbsp;of this Section&nbsp;6. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(h) <U>Officer&#146;s Certificate</U>. The Company shall have furnished to the Representative a certificate, dated each Closing Date, of its Chairman of the
Board or President and its Chief Financial Officer stating in their respective capacities as officers of the Company on behalf of the Company that (i)&nbsp;no stop order suspending the effectiveness of the Registration Statement (including, for
avoidance of doubt, any Rule 462(b) Registration Statement), or any post-effective amendment thereto, shall be in effect and no proceedings for such purpose shall have been instituted or, to their knowledge, threatened by the Commission,
(ii)&nbsp;for the period from and including the date of this Agreement through and including each Closing Date, there has not occurred any Material Adverse Effect, (iii)&nbsp;to their knowledge, after reasonable investigation, as of each Closing
Date, the representations and warranties of the Company in this Agreement are true and correct and the Company has complied with all agreements and satisfied all conditions on its part to be performed or satisfied hereunder at or prior to each
Closing Date, and (iv)&nbsp;there has not been, subsequent to the date of the most recent audited financial statements included or incorporated by reference in the General Disclosure Package, any Material Adverse Effect in the financial position or
results of operations of the Company, or any change or development that, singularly or in the aggregate, would reasonably be expected to involve a Material Adverse Effect, except as set forth in the General Disclosure Package and the Prospectus.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(i) <U>No Material Adverse Effect</U>. Since the date of the latest audited financial statements included in the General Disclosure Package or
incorporated by reference in the General Disclosure Package as of the date hereof, (i)&nbsp;neither the Company nor any of its subsidiaries shall have sustained any loss or interference with its business from fire, explosion, flood or other
calamity, whether or not covered by insurance, or from any labor dispute or court or governmental action, order or decree, otherwise than as set forth in the General Disclosure Package, and (ii)&nbsp;there shall not have been any change in the
capital stock or long-term debt of the Company or any of its subsidiaries (other than stock option and warrant exercises and stock repurchases in the ordinary course of business and repayments of existing indebtedness), or any change, or any
development involving a prospective change, in or affecting the business, general affairs, management, financial position, stockholders&#146; equity or results of operations of the Company and its subsidiaries, otherwise than as set forth in the
General Disclosure Package, the effect of which, in any such case described in clause (i)&nbsp;or (ii) of this paragraph (i), is, in the judgment of the Representative, so material and adverse as to make it impracticable or inadvisable to proceed
with the sale or delivery of the Stock on the terms and in the manner contemplated in the General Disclosure Package. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(j) <U>No Legal Impediment to
Issuance</U>. No action shall have been taken and no law, statute, rule, regulation or order shall have been enacted, adopted or issued by any governmental or regulatory agency or body which would prevent the issuance or sale of the Stock; and no
injunction, restraining order or order of any other nature by any federal or state court of competent jurisdiction shall have been issued which would prevent the issuance or sale of the Stock or materially and adversely affect or potentially
materially and adversely affect the business or operations of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(k) <U>No Downgrade</U>. Subsequent to the execution and delivery of this
Agreement (i)&nbsp;no downgrading shall have occurred in the Company&#146;s corporate credit rating or the rating accorded the Company&#146;s debt securities by any &#147;nationally recognized statistical rating organization,&#148; as that term is
defined by the Commission for purposes of Rule 436(g)(2) of the Rules and Regulations and (ii)&nbsp;no such organization shall have publicly announced that it has under surveillance or review (other than an announcement with positive implications of
a possible upgrading), the Company&#146;s corporate credit rating or the rating of any of the Company&#146;s debt securities. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(l) <U>Market Conditions</U>. Subsequent to the execution and delivery of this Agreement there shall not
have occurred any of the following: (i)&nbsp;trading in any of the Company&#146;s securities shall have been suspended or materially limited by the Commission or The Nasdaq Global Select Market, or trading in securities generally on the New York
Stock Exchange, Nasdaq Global Select Market, Nasdaq Global Market, Nasdaq Capital Market or the NYSE MKT LLC or in the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">over-the-counter</FONT></FONT> market, or trading in any
securities of the Company on any exchange or in the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">over-the-counter</FONT></FONT> market, shall have been suspended or materially limited, or minimum or maximum prices or maximum
range for prices shall have been established on any such exchange or such market by the Commission, by such exchange or market or by any other regulatory body or governmental authority having jurisdiction, (ii)&nbsp;a banking moratorium shall have
been declared by Federal or state authorities or a material disruption has occurred in commercial banking or securities settlement or clearance services in the United States, (iii)&nbsp;the United States shall have become engaged in hostilities, or
the subject of an act of terrorism, or there shall have been an outbreak of or escalation in hostilities involving the United States, or there shall have been a declaration of a national emergency or war by the United States or there shall have been
a health epidemic or pandemic outbreak of infectious disease (including <FONT STYLE="white-space:nowrap">COVID-19</FONT> to the extent that there is a material worsening of such outbreak that actually occurs after the date hereof in the markets in
which the Company operates) or (iv)&nbsp;there shall have occurred such a material adverse change in general economic, political or financial conditions (or the effect of international conditions on the financial markets in the United States shall
be such) as to make it, in the judgment of the Representative, impracticable or inadvisable to proceed with the sale or delivery of the Stock on the terms and in the manner contemplated in the General Disclosure Package and the Prospectus. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(m) <U>Exchange Listing</U>. The Nasdaq Global Select Market shall have approved the Stock for listing therein, subject only to official notice of issuance.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(n) <U>Good Standing</U>. The Representative shall have received on and as of each Closing Date satisfactory evidence of the good standing of the Company
and certain of its subsidiaries in their respective jurisdictions of organization and their good standing as foreign entities in such other jurisdictions as the Representative may reasonably request, in each case in writing or any standard form of
telecommunication from the appropriate Governmental Authorities of such jurisdictions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(o) <U><FONT STYLE="white-space:nowrap">Lock-Up</FONT>
Agreements</U>. The Representative shall have received the written agreements, substantially in the form of <U>Exhibit A</U> hereto, of the officers and directors of the Company listed in <U>Schedule D</U> to this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(p) <U>Secretary&#146;s Certificate</U>. The Company shall have furnished to the Representative a Secretary&#146;s Certificate of the Company, in form and
substance reasonably satisfactory to counsel for the Underwriters and customary for the type of offering contemplated by this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(q) <U>Chief
Financial Officer&#146;s Certificate of the Company</U>. The Company shall have furnished to the Representative certificates, (i)&nbsp;dated as of the date hereof and (ii)&nbsp;dated as of each Closing Date, of its Chief Financial Officer, in form
and substance reasonably satisfactory to counsel for the Underwriters and customary for the type of offering contemplated by this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(r)
<U>Additional Document</U>. On or prior to each Closing Date, the Company shall have furnished to the Representative such further certificates and documents as the Representative may reasonably request. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">All opinions, letters, evidence and certificates mentioned above or elsewhere in this Agreement shall be deemed to be in compliance with the provisions hereof
only if they are in form and substance reasonably satisfactory to counsel for the Underwriters. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>7. INDEMNIFICATION AND CONTRIBUTION. </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(a) <U>Indemnification of Underwriters by the Company</U>. The Company shall indemnify and hold harmless each Underwriter, its affiliates, directors,
officers, managers, members, employees, representatives and agents and each person, if any, who controls any Underwriter within the meaning of Section&nbsp;15 of the Securities Act or Section&nbsp;20 of the Exchange Act (collectively the
&#147;<B>Underwriter Indemnified Parties</B>,&#148; and each an &#147;<B>Underwriter Indemnified Party</B>&#148;) against any loss, claim, damage, expense or liability whatsoever (or any action, investigation or proceeding in respect thereof), joint
or several, to which such Underwriter Indemnified Party may become subject, under the Securities Act or otherwise, insofar as such loss, claim, damage, expense, liability, action, investigation or proceeding arises out of or is based upon
(A)&nbsp;any untrue statement or alleged untrue statement of a material fact contained in any Preliminary Prospectus, any Issuer Free Writing Prospectus, any &#147;issuer information&#148; filed or required to be filed pursuant to Rule 433(d) of the
Rules and Regulations, the Registration Statement, the Prospectus, or in any amendment or supplement thereto, or document incorporated by reference therein or in any materials or information provided to investors by, or with the approval of, the
Company in connection with the marketing of the offering of the Common Stock, including any roadshow or investor presentations made to investors by </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the Company (whether in person or electronically) (&#147;<B>Marketing Materials</B>&#148;) or (B)&nbsp;the omission or alleged omission to state in any Preliminary Prospectus, any Issuer Free
Writing Prospectus, any &#147;issuer information&#148; filed or required to be filed pursuant to Rule 433(d) of the Rules and Regulations, the Registration Statement or the Prospectus, or in any amendment or supplement thereto, or document
incorporated by reference therein, or in any Marketing Materials, a material fact required to be stated therein or necessary to make the statements therein not misleading, and shall reimburse each Underwriter Indemnified Party promptly upon demand
for any legal fees or other expenses reasonably incurred by that Underwriter Indemnified Party in connection with investigating, or preparing to defend, or defending against, or appearing as a third party witness in respect of, or otherwise incurred
in connection with, any such loss, claim, damage, expense, liability, action, investigation or proceeding, as such fees and expenses are incurred; <I>provided</I>, <I>however</I>, that the Company shall not be liable in any such case to the extent
that any such loss, claim, damage, expense or liability arises out of or is based upon an untrue statement or alleged untrue statement in, or omission or alleged omission from any Preliminary Prospectus, the Registration Statement or the Prospectus,
or any such amendment or supplement thereto, any Issuer Free Writing Prospectus or any Marketing Materials made in reliance upon and in conformity with written information furnished to the Company through the Representative by or on behalf of any
Underwriter specifically for use therein, which information the parties hereto agree is limited to the Underwriters&#146; Information. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The indemnity
agreement in this Section&nbsp;7(a) is not exclusive and is in addition to each other liability which the Company might have under this Agreement or otherwise, and shall not limit any rights or remedies which may otherwise be available under this
Agreement, at law or in equity to any Underwriter Indemnified Party. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(b) <U>Indemnification of Company by the Underwriters</U>. Each Underwriter,
severally and not jointly, shall indemnify and hold harmless the Company and its directors, its officers who signed the Registration Statement and each person, if any, who controls the Company within the meaning of Section&nbsp;15 of the Securities
Act or Section&nbsp;20 of the Exchange Act (collectively the &#147;<B>Company Indemnified Parties</B>&#148; and each a &#147;<B>Company Indemnified Party</B>&#148;) against any loss, claim, damage, expense or liability whatsoever (or any action,
investigation or proceeding in respect thereof), joint or several, to which such Company Indemnified Party may become subject, under the Securities Act or otherwise, insofar as such loss, claim, damage, expense, liability, action, investigation or
proceeding arises out of or is based upon (i)&nbsp;any untrue statement or alleged untrue statement of a material fact contained in any Preliminary Prospectus, any Issuer Free Writing Prospectus, any &#147;issuer information&#148; filed or required
to be filed pursuant to Rule 433(d) of the Rules and Regulations, the Registration Statement or the Prospectus, or in any amendment or supplement thereto, or (ii)&nbsp;the omission or alleged omission to state in any Preliminary Prospectus, any
Issuer Free Writing Prospectus, any &#147;issuer information&#148; filed or required to be filed pursuant to Rule 433(d) of the Rules and Regulations, the Registration Statement or the Prospectus, or in any amendment or supplement thereto, a
material fact required to be stated therein or necessary to make the statements therein not misleading, but in each case only to the extent that the untrue statement or alleged untrue statement or omission or alleged omission was made in reliance
upon and in conformity with written information furnished to the Company through the Representative by or on behalf of that Underwriter specifically for use therein, which information the parties hereto agree is limited to the Underwriters&#146;
Information, and shall reimburse the Company Indemnified Parties for any legal or other expenses reasonably incurred by such party in connection with investigating or preparing to defend or defending against or appearing as third party witness in
connection with any such loss, claim, damage, liability, action, investigation or proceeding, as such fees and expenses are incurred. This indemnity agreement is not exclusive and will be in addition to any liability which the Underwriters might
otherwise have and shall not limit any rights or remedies which may otherwise be available under this Agreement, at law or in equity to the Company Indemnified Parties. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(c) Promptly after receipt by an indemnified party under this Section&nbsp;7 of notice of the commencement of any action, the indemnified party shall, if a
claim in respect thereof is to be made against an indemnifying party under this Section&nbsp;7, notify such indemnifying party in writing of the commencement of that action; <I>provided, however,</I> that the failure to notify the indemnifying party
shall not relieve it from any liability which it may have under this Section&nbsp;7 except to the extent it has been materially prejudiced by such failure; and, <I>provided, further,</I> that the failure to notify an indemnifying party shall not
relieve it from any liability which it may have to an indemnified party otherwise than under this Section&nbsp;7. If any such action shall be brought against an indemnified party, and it shall notify the indemnifying party thereof, the indemnifying
party shall be entitled to participate therein and, to the extent that it wishes, jointly with any other similarly notified indemnifying party, to assume the defense of such action with counsel reasonably satisfactory to the indemnified party (which
counsel shall not, except with the written consent of the indemnified party, be counsel to the indemnifying party). After notice from the indemnifying party to the indemnified party of its election to assume the defense of such action, except as
provided herein, the indemnifying party shall not be liable to the indemnified party under Section&nbsp;7 for any legal or other expenses subsequently incurred by the indemnified party in connection with the defense of such action other than
reasonable costs of investigation; <I>provided, however,</I> that any indemnified party shall have the right to employ separate counsel in any such action and to participate in the defense of such action but the fees and expenses of such counsel
(other than reasonable costs of investigation) shall be at the expense of such indemnified party unless (i)&nbsp;the employment thereof has been specifically authorized in writing by the Company in the case of a claim for indemnification under
Section&nbsp;7(a) or the Representative in </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the case of a claim for indemnification under Section&nbsp;7(b), (ii) such indemnified party shall have been advised by its counsel that there may be one or more legal defenses available to it
which are different from or additional to those available to the indemnifying party, or (iii)&nbsp;the indemnifying party has failed to assume the defense of such action and employ counsel reasonably satisfactory to the indemnified party within a
reasonable period of time after notice of the commencement of the action or the indemnifying party does not diligently defend the action after assumption of the defense, in which case, if such indemnified party notifies the indemnifying party in
writing that it elects to employ separate counsel at the expense of the indemnifying party, the indemnifying party shall not have the right to assume the defense of (or, in the case of a failure to diligently defend the action after assumption of
the defense, to continue to defend) such action on behalf of such indemnified party and the indemnifying party shall be responsible for legal or other expenses subsequently incurred by such indemnified party in connection with the defense of such
action; <I>provided</I>, <I>however</I>, that the indemnifying party shall not, in connection with any one such action or separate but substantially similar or related actions in the same jurisdiction arising out of the same general allegations or
circumstances, be liable for the reasonable fees and expenses of more than one separate firm of attorneys at any time for all such indemnified parties (in addition to any local counsel), which firm shall be designated in writing by the
Representative if the indemnified parties under this Section&nbsp;7 consist of any Underwriter Indemnified Party or by the Company if the indemnified parties under this Section&nbsp;7 consist of any Company Indemnified Parties. Subject to this
Section&nbsp;7(c), the amount payable by an indemnifying party under Section&nbsp;7 shall include, but not be limited to, (x)&nbsp;reasonable legal fees and expenses of counsel to the indemnified party and any other expenses in investigating, or
preparing to defend or defending against, or appearing as a third party witness in respect of, or otherwise incurred in connection with, any action, investigation, proceeding or claim, and (y)&nbsp;all amounts paid in settlement of any of the
foregoing. No indemnifying party shall, without the prior written consent of the indemnified parties, settle or compromise or consent to the entry of judgment with respect to any pending or threatened action or any claim whatsoever, in respect of
which indemnification or contribution could be sought under this Section&nbsp;7 (whether or not the indemnified parties are actual or potential parties thereto), unless such settlement, compromise or consent (i)&nbsp;includes an unconditional
release of each indemnified party in form and substance reasonably satisfactory to such indemnified party from all liability arising out of such action or claim and (ii)&nbsp;does not include a statement as to or an admission of fault, culpability
or a failure to act by or on behalf of any indemnified party. Subject to the provisions of the following sentence, no indemnifying party shall be liable for settlement of any pending or threatened action or any claim whatsoever that is effected
without its written consent (which consent shall not be unreasonably withheld or delayed), but if settled with its written consent, if its consent has been unreasonably withheld or delayed or if there be a judgment for the plaintiff in any such
matter, the indemnifying party agrees to indemnify and hold harmless any indemnified party from and against any loss or liability by reason of such settlement or judgment. In addition, if at any time an indemnified party shall have requested that an
indemnifying party reimburse the indemnified party for fees and expenses of counsel, such indemnifying party agrees that it shall be liable for any settlement of the nature contemplated by Section&nbsp;7(a) effected without its written consent if
(i)&nbsp;such settlement is entered into more than forty-five (45)&nbsp;days after receipt by such indemnifying party of the request for reimbursement, (ii)&nbsp;such indemnifying party shall have received notice of the terms of such settlement at
least thirty (30)&nbsp;days prior to such settlement being entered into and (iii)&nbsp;such indemnifying party shall not have reimbursed such indemnified party in accordance with such request prior to the date of such settlement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(d) If the indemnification provided for in this Section&nbsp;7 is unavailable or insufficient to hold harmless an indemnified party under Section&nbsp;7(a) or
7(b), then each indemnifying party shall, in lieu of indemnifying such indemnified party, contribute to the amount paid, payable or otherwise incurred by such indemnified party as a result of such loss, claim, damage, expense or liability (or any
action, investigation or proceeding in respect thereof), as incurred, (i)&nbsp;in such proportion as shall be appropriate to reflect the relative benefits received by the Company on the one hand and the Underwriters on the other from the offering of
the Stock, or (ii)&nbsp;if the allocation provided by clause (i)&nbsp;of this Section&nbsp;7(d) is not permitted by applicable law, in such proportion as is appropriate to reflect not only the relative benefits referred to in clause (i)&nbsp;of this
Section&nbsp;7(d) but also the relative fault of the Company on the one hand and the Underwriters on the other with respect to the statements, omissions, acts or failures to act which resulted in such loss, claim, damage, expense or liability (or
any action, investigation or proceeding in respect thereof) as well as any other relevant equitable considerations. The relative benefits received by the Company on the one hand and the Underwriters on the other with respect to such offering shall
be deemed to be in the same proportion as the total net proceeds from the offering of the Stock purchased under this Agreement (before deducting expenses) received by the Company bear to the total underwriting discounts and commissions received by
the Underwriters with respect to the Stock purchased under this Agreement, in each case as set forth in the table on the cover page of the Prospectus. The relative fault of the Company on the one hand and the Underwriters on the other shall be
determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission or alleged omission to state a material fact relates to information supplied by the Company on the one hand or the
Underwriters on the other, the intent of the parties and their relative knowledge, access to information and opportunity to correct or prevent such untrue statement, omission, act or failure to act; <I>provided</I> that the parties hereto agree that
the written information furnished to the Company through the Representative by or on behalf of the Underwriters for use in the Preliminary Prospectus, the Registration Statement or the Prospectus, or in any amendment or supplement thereto, consists
solely of the Underwriters&#146; Information. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(e) The Company and the Underwriters agree that it would not be just and equitable if contributions pursuant
to Section&nbsp;7(d) above were to be determined by pro rata allocation or by any other method of allocation which does not take into account the equitable considerations referred to Section&nbsp;7(d) above. The amount paid or payable by an
indemnified party as a result of the loss, claim, damage, expense, liability, action, investigation or proceeding referred to in Section&nbsp;7(d) above shall be deemed to include, subject to the limitations set forth above, any legal or other
expenses reasonably incurred by such indemnified party in connection with investigating, preparing to defend or defending against or appearing as a third party witness in respect of, or otherwise incurred in connection with, any such loss, claim,
damage, expense, liability, action, investigation or proceeding. Notwithstanding the provisions of this Section&nbsp;7, no Underwriters shall be required to contribute any amount in excess of the amount by which the total underwriting discounts and
commissions received by such Underwriter with respect to the offering of the Stock exceeds the amount of any damages which the Underwriter has otherwise paid or become liable to pay by reason of any untrue or alleged untrue statement, omission or
alleged omission, act or alleged act or failure to act or alleged failure to act. No person guilty of fraudulent misrepresentation (within the meaning of Section&nbsp;11(f) of the Securities Act) shall be entitled to contribution from any person who
was not guilty of such fraudulent misrepresentation. The Underwriters&#146; obligations to contribute as provided in this Section&nbsp;7 are several in proportion to their respective underwriting obligations and not joint. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">8. <I>TERMINATION</I>. The obligations of the Underwriters hereunder may be terminated by the Representative, in its absolute discretion by written notice
given to the Company prior to delivery of and payment for the Firm Stock if, prior to that time, any of the events described in Sections 6(i), 6(j), 6(k) or 6(l) have occurred or if the Underwriters shall decline to purchase the Stock for any reason
permitted under this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">9. <I>REIMBURSEMENT OF UNDERWRITERS&#146; EXPENSES</I>. Notwithstanding anything to the contrary in this Agreement, if
(a)&nbsp;this Agreement shall have been terminated pursuant to Section&nbsp;8 or 10, (b) the Company shall fail to tender the Stock for delivery to the Underwriters for any reason not permitted under this Agreement, (c)&nbsp;the Underwriters shall
decline to purchase the Stock for any reason permitted under this Agreement or (d)&nbsp;the sale of the Stock is not consummated because any condition to the obligations of the Underwriters set forth herein is not satisfied or because of the
refusal, inability or failure on the part of the Company to perform any agreement herein or to satisfy any condition or to comply with the provisions hereof, then the Company shall reimburse the Underwriters (notwithstanding the provisions of
Section&nbsp;5) for the fees and expenses of Underwriters&#146; counsel and for such other <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> expenses as shall have been reasonably incurred by them in
connection with this Agreement and the proposed purchase of the Stock, including, without limitation, travel and lodging expenses of the Underwriters, and upon demand the Company shall pay the full amount thereof to the Representative;
<I>provided</I> that if this Agreement is terminated pursuant to Section&nbsp;10 by reason of the default of one or more Underwriters, the Company shall not be obligated to reimburse any defaulting Underwriter on account of expenses to the extent
incurred by such defaulting Underwriter <I>provided further</I> that the foregoing shall not limit any reimbursement obligation of the Company to any <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Underwriter under this Section&nbsp;9. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">10. <I>SUBSTITUTION OF UNDERWRITERS</I>. If any Underwriter or Underwriters shall default in its or their obligations to purchase shares of Stock hereunder on
any Closing Date and the aggregate number of shares which such defaulting Underwriter or Underwriters agreed but failed to purchase does not exceed ten percent (10%) of the total number of shares to be purchased by all Underwriters on such Closing
Date, the other Underwriters shall be obligated severally, in proportion to their respective commitments hereunder, to purchase the shares which such defaulting Underwriter or Underwriters agreed but failed to purchase on such Closing Date. If any
Underwriter or Underwriters shall so default and the aggregate number of shares with respect to which such default or defaults occur is more than ten percent (10%) of the total number of shares to be purchased by all Underwriters on such Closing
Date and arrangements satisfactory to the Representative and the Company for the purchase of such shares by other persons are not made within forty-eight (48)&nbsp;hours after such default, this Agreement shall terminate. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If the remaining Underwriters or substituted Underwriters are required hereby or agree to take up all or part of the shares of Stock of a defaulting
Underwriter or Underwriters on such Closing Date as provided in this Section&nbsp;10, (i) the Company shall have the right to postpone such Closing Date for a period of not more than five (5)&nbsp;full business days in order that the Company may
effect whatever changes may thereby be made necessary in the Registration Statement or the Prospectus, or in any other documents or arrangements, and the Company agrees promptly to file any amendments to the Registration Statement or supplements to
the Prospectus which may thereby be made necessary, and (ii)&nbsp;the respective numbers of shares to be purchased by the remaining Underwriters or substituted Underwriters shall be taken as the basis of their underwriting obligation for all
purposes of this Agreement. Nothing herein contained shall relieve any defaulting Underwriter of its liability to the Company or the other Underwriters for damages occasioned by its default hereunder. Any termination of this Agreement pursuant to
this Section&nbsp;10 shall be without liability on the part of any <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Underwriter or the Company, except that the representations, warranties, covenants, indemnities, agreements and other
statements set forth in Section&nbsp;2, the obligations with respect to expenses to be paid or reimbursed pursuant to Sections 5 and 9 and the provisions of Section&nbsp;7 and Sections 11 through 21, inclusive, shall not terminate and shall remain
in full force and effect. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">11. <I>ABSENCE OF FIDUCIARY RELATIONSHIP. </I>The Company acknowledges and agrees that: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(a) each Underwriter&#146;s responsibility to the Company is solely contractual in nature, the Representative has been retained solely to act as underwriter in
connection with the sale of the Stock and no fiduciary, advisory or agency relationship between the Company and the Representative has been created in respect of any of the transactions contemplated by this Agreement, irrespective of whether the
Representative has advised or is advising the Company on other matters; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(b) the price of the Stock set forth in this Agreement was established by the
Company following discussions and arms-length negotiations with the Representative, and the Company is capable of evaluating and understanding, and understands and accepts, the terms, risks and conditions of the transactions contemplated by this
Agreement; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(c) it has been advised that the Representative and its affiliates are engaged in a broad range of transactions which may involve interests
that differ from those of the Company and that the Representative has no obligation to disclose such interests and transactions to the Company by virtue of any fiduciary, advisory or agency relationship; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(d) it waives, to the fullest extent permitted by law, any claims it may have against the Representative for breach of fiduciary duty or alleged breach of
fiduciary duty and agrees that the Representative shall have no liability (whether direct or indirect) to the Company in respect of such a fiduciary duty claim or to any person asserting a fiduciary duty claim on behalf of or in right of the
Company, including stockholders, employees or creditors of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">12. <I>SUCCESSORS; PERSONS ENTITLED TO BENEFIT OF AGREEMENT</I>. This Agreement
shall inure to the benefit of and be binding upon the several Underwriters, the Company and their respective successors and assigns. Nothing expressed or mentioned in this Agreement is intended or shall be construed to give any person, other than
the persons mentioned in the preceding sentence, any legal or equitable right, remedy or claim under or in respect of this Agreement, or any provisions herein contained, this Agreement and all conditions and provisions hereof being intended to be
and being for the sole and exclusive benefit of such persons and for the benefit of no other person; except that the representations, warranties, covenants, agreements and indemnities of the Company contained in this Agreement shall also be for the
benefit of the Underwriter Indemnified Parties, and the indemnities of the several Underwriters shall be for the benefit of the Company Indemnified Parties. It is understood that each Underwriter&#146;s responsibility to the Company is solely
contractual in nature and the Underwriters do not owe the Company, or any other party, any fiduciary duty as a result of this Agreement. No purchaser of any of the Stock from any Underwriter shall be deemed to be a successor or assign by reason
merely of such purchase. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">13. <I>SURVIVAL OF INDEMNITIES, REPRESENTATIONS, WARRANTIES, ETC. </I>The respective indemnities, covenants, agreements,
representations, warranties and other statements of the Company and the several Underwriters, as set forth in this Agreement or made by them respectively, pursuant to this Agreement, shall remain in full force and effect, regardless of any
investigation made by or on behalf of any Underwriter, the Company or any person controlling any of them and shall survive delivery of and payment for the Stock. Notwithstanding any termination of this Agreement, including without limitation any
termination pursuant to Section&nbsp;8 or Section&nbsp;10, the indemnities, covenants, agreements, representations, warranties and other statements forth in Sections 2, 5, 7 and 9 and Sections 11 through 21, inclusive, of this Agreement shall not
terminate and shall remain in full force and effect at all times. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">14. <I>NOTICES</I>. All statements, requests, notices and agreements hereunder shall be
in writing, and: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(a) if to the Underwriters, shall be delivered or sent by mail, telex, facsimile transmission or email to Oppenheimer&nbsp;&amp; Co.
Inc., 85 Broad Street, New York, New York 10004, Attention: Equity Capital Markets, with a copy to Oppenheimer&nbsp;&amp; Co. Inc., 85 Broad Street, New York, New York 10004 Attention: General Counsel, with a copy to White&nbsp;&amp; Case LLP, 1221
Avenue of the Americas, New York, New York 10020, Attention: Jessica Y. Chen; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(b) if to the Company shall be delivered or sent by mail, telex,
facsimile transmission or email to American Superconductor Corporation, 114 East Main Street, Ayer, Massachusetts 01432, Attention: John Kosiba, email [***]; with a copy to John Samia, <FONT STYLE="white-space:nowrap">e-mail</FONT> [***], with a
copy to Latham&nbsp;&amp; Watkins LLP, 200 Clarendon Street, Boston, Massachusetts 02116, Attention: Peter N. Handrinos, Wesley C. Holmes; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>provided,
however,</I> that any notice to an Underwriter pursuant to Section&nbsp;7 shall be delivered or sent by mail, or facsimile transmission to such Underwriter at its address set forth in its acceptance telex to the Representative, which address will be
supplied to any other party hereto by the Representative upon request. Any such statements, requests, notices or agreements shall take effect at the time of receipt thereof. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">15. <I>DEFINITION OF CERTAIN TERMS</I>. For purposes of this Agreement, (a) &#147;<B>affiliate</B>&#148; has
the meaning set forth in Rule 405 under the Securities Act, (b) &#147;<B>business day</B>&#148; means any day on which the New York Stock Exchange, Inc. is open for trading and (c) &#147;<B>subsidiary</B>&#148; has the meaning set forth in Rule 405
of the Rules and Regulations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">16. <B><I>GOVERNING LAW AND JURISDICTION</I></B><I>.</I><B> This Agreement shall be governed by and construed in accordance
with the laws of the State of New York. </B>The Company irrevocably (a)&nbsp;submits to the <FONT STYLE="white-space:nowrap">non-exclusive</FONT> jurisdiction of the Federal and state courts in the Borough of Manhattan in The City of New York for
the purpose of any suit, action or other proceeding arising out of this Agreement or the transactions contemplated by this Agreement, the Registration Statement and any Preliminary Prospectus or the Prospectus, (b)&nbsp;agrees that all claims in
respect of any such suit, action or proceeding may be heard and determined by any such court, (c)&nbsp;waives to the fullest extent permitted by applicable law, any immunity from the jurisdiction of any such court or from any legal process,
(d)&nbsp;agrees not to commence any such suit, action or proceeding other than in such courts, and (e)&nbsp;waives, to the fullest extent permitted by applicable law, any claim that any such suit, action or proceeding is brought in an inconvenient
forum. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">17. <I>UNDERWRITERS&#146; INFORMATION.</I> The parties hereto acknowledge and agree that, for all purposes of this Agreement, the
Underwriters&#146; Information consists solely of the following information in the Prospectus: (i)&nbsp;the last paragraph on the front cover page concerning the terms of the offering by the Underwriters; and (ii)&nbsp;the statements concerning the
Underwriters contained in the fourth, eleventh, twelfth and thirteenth paragraphs under the heading &#147;Underwriting.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">18. <I>AUTHORITY OF THE
REPRESENTATIVE</I>. In connection with this Agreement, the Representative will act for and on behalf of the several Underwriters, and any action taken under this Agreement by the Representative will be binding on all the Underwriters. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">19. <I>PARTIAL UNENFORCEABILITY</I>. The invalidity or unenforceability of any section, paragraph, clause or provision of this Agreement shall not affect the
validity or enforceability of any other section, paragraph, clause or provision hereof. If any section, paragraph, clause or provision of this Agreement is for any reason determined to be invalid or unenforceable, there shall be deemed to be made
such minor changes (and only such minor changes) as are necessary to make it valid and enforceable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">20. <I>GENERAL</I>. This Agreement constitutes the
entire agreement of the parties to this Agreement and supersedes all prior written or oral and all contemporaneous oral agreements, understandings and negotiations with respect to the subject matter hereof. Accordingly, the Engagement Letter, dated
January&nbsp;18, 2024, by and between the Company and the Representative (the &#147;<B>Engagement Letter</B>&#148;) and all provisions and obligations thereunder, including, without limitation, the indemnification provision in Section&nbsp;6 and
Annex A of such Engagement Letter, shall terminate upon the Closing Date, regardless of any inconsistent survival provisions in such Engagement Letter. In this Agreement, the masculine, feminine and neuter genders and the singular and the plural
include one another. The section headings in this Agreement are for the convenience of the parties only and will not affect the construction or interpretation of this Agreement. This Agreement may be amended or modified, and the observance of any
term of this Agreement may be waived, only by a writing signed by the Company and the Representative. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">21. <I>COUNTERPARTS</I>. This Agreement may be
signed in any number of counterparts, each of which shall be an original, including by facsimile or other electronic transmission, with the same effect as if the signatures thereto and hereto were upon the same instrument. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature page follows</I>] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If the foregoing is in accordance with your understanding please indicate your acceptance of this Agreement
by signing in the space provided for that purpose below. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Very truly yours,</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">AMERICAN SUPERCONDUCTOR CORPORATION</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ John W. Kosiba</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Name: John W. Kosiba</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Title: SVP and
CFO</P></TD></TR></TABLE></DIV> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Accepted as of the date first above written:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">OPPENHEIMER&nbsp;&amp; CO. INC.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Acting on its own behalf and as Representative of several Underwriters listed on <U>Schedule</U> A to this Agreement.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">By: OPPENHEIMER&nbsp;&amp; CO. INC.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Peter Bennett</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Name: Peter Bennett</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Title: Managing Director Head of Equity Capital Markets</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>[Signature Page to Underwriting Agreement] </I></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SCHEDULE A </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="85%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">Name</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Number&nbsp;of<BR>Shares of<BR>Firm&nbsp;Stock<BR>to&nbsp;be<br>Purchased</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Number&nbsp;of<BR>Shares&nbsp;of<BR>Optional<BR>Stock&nbsp;to&nbsp;be<br>Purchased</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Oppenheimer&nbsp;&amp; Co. Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,780,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">567,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Craig-Hallum Capital Group LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">810,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">121,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Roth Capital Partners, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">810,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">121,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5,400,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">810,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SCHEDULE B </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Issuer Free Writing Prospectuses </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">None. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SCHEDULE C </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Pricing Information </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Firm Stock to be Sold:
5,400,000 shares </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Optional Stock to be Sold: 810,000 shares </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Public Offering Price: $11.25 per share </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Underwriting Discounts
and Commissions: $0.675 per share </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Estimated Net Proceeds to the Company (after underwriting discounts and commissions, but before transaction expenses
and excluding the issuance of Optional Stock): $57,105,000 </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SCHEDULE D </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">List of officers and directors subject to Section&nbsp;4(k). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Directors and Executive Officers </U></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Daniel P. McGahn </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Arthur H. House </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Barbara G. Littlefield </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">David R. Oliver, Jr. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">John W. Kosiba, Jr. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Laura A. Dambier </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Margaret D. Klein </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SCHEDULE E </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Neeltran, Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Northeast Power Systems, Inc. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Exhibit A </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Form of <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreement </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">January&#8195;, 2024 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Oppenheimer&nbsp;&amp; Co.
Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As Representative of the Several Underwriters </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">c/o
Oppenheimer&nbsp;&amp; Co. Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">85 Broad Street </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">New York,
New York 10004 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Re: American Superconductor Corporation &#150; Registration Statement on Form <FONT STYLE="white-space:nowrap">S-3</FONT> for Shares of
Common Stock </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dear Ladies and Gentlemen: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This Agreement is
being delivered to you in connection with the proposed Underwriting Agreement (the &#147;<B>Underwriting Agreement</B>&#148;) between American Superconductor Corporation, a Delaware corporation (the &#147;<B>Company</B>&#148;), and
Oppenheimer&nbsp;&amp; Co. Inc. (&#147;<B>Oppenheimer</B>&#148;), as representative of a group of underwriters (collectively, the &#147;<B>Underwriters</B>&#148;) to be named therein, relating to the proposed public offering of shares of the common
stock, par value $0.01 per share (the &#147;<B>Common Stock</B>&#148;) of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In order to induce you and the other Underwriters to enter into
the Underwriting Agreement, and in light of the benefits that the offering of the Common Stock will confer upon the undersigned in its capacity as a securityholder and/or an officer, director or employee of the Company, and for good and valuable
consideration, the receipt and sufficiency of which are hereby acknowledged, the undersigned agrees with each Underwriter that, during the period beginning on the date hereof through and including the date that is the 90th day after the date of the
Underwriting Agreement (the &#147;<B><FONT STYLE="white-space:nowrap">Lock-Up</FONT> Period</B>&#148;), the undersigned will not, without the prior written consent of Oppenheimer, directly or indirectly, (i)&nbsp;offer, sell, assign, transfer,
pledge, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, lend or otherwise transfer or dispose of, or announce the intention to otherwise transfer or
dispose of, any shares of Common Stock (including, without limitation, Common Stock which may be deemed to be beneficially owned by the undersigned in accordance with the rules and regulations promulgated under the Securities Act of 1933, as the
same may be amended or supplemented from time to time (such shares, the &#147;<B>Beneficially Owned Shares</B>&#148;)) or securities convertible into or exercisable or exchangeable for Common Stock, (ii)&nbsp;enter into any swap, hedge or similar
agreement or arrangement that transfers in whole or in part, the economic risk of ownership of the Beneficially Owned Shares or securities convertible into or exercisable or exchangeable for Common Stock, whether now owned or hereafter acquired by
the undersigned or with respect to which the undersigned has or hereafter acquires the power of disposition, and whether any such transaction described in clause (i)&nbsp;or (ii) above is to be settled by delivery of Common Stock or such other
securities, in cash or otherwise, or (iii)&nbsp;engage in any short selling of the Common Stock or securities convertible into or exercisable or exchangeable for Common Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The restrictions set forth in the immediately preceding paragraph shall not apply to: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(1) any transfers made by the undersigned (a)&nbsp;as a bona fide gift to any member of the immediate family (as defined below) of the undersigned or to a
trust the beneficiaries of which are exclusively the undersigned or members of the undersigned&#146;s immediate family, (b)&nbsp;by will or intestate succession upon the death of the undersigned or (c)&nbsp;as a bona fide gift to a charity or
educational institution, </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(2) transactions relating to Common Stock or other securities convertible into or exercisable or exchangeable for Common Stock
acquired in open market transactions after completion of the Offering, provided that no such transaction is required to be, or is, publicly announced (whether on Form 4, Form 5 or otherwise) during the <FONT STYLE="white-space:nowrap">Lock-Up</FONT>
Period, </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(3) the entry, by the undersigned, at any time on or after the date of the Underwriting Agreement, of any trading plan providing for the sale of
Common Stock by the undersigned, which trading plan meets the requirements of Rule <FONT STYLE="white-space:nowrap">10b5-1(c)</FONT> under the Securities Exchange Act of 1934, as amended (a &#147;<B><FONT STYLE="white-space:nowrap">10b5-1</FONT>
Plan</B>&#148;), provided, however, that such plan does not provide for, or permit, the sale of any Common Stock during the <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Period and to the extent a public announcement or filing under the Securities
Exchange Act of 1934, as amended (the &#147;<B>Exchange Act</B>&#148;), if any, is required of or voluntarily made by or on behalf of the undersigned or the Company regarding the entry of such plan, such announcement or filing shall include a
statement to the effect that no transfer of Common Stock may be made under such plan during the <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Period, </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(4) transfers pursuant to a <FONT STYLE="white-space:nowrap">10b5-1</FONT> Plan established prior to the
date hereof for the transfer of shares of Common Stock of the undersigned, a copy of which has been provided to the Underwriters prior to the date hereof, provided, that no public filing, report or announcement shall be voluntarily made, and that
any filing required to be made under the Exchange Act during the <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Period in connection with such a transfer shall disclose that such transfer was made pursuant to a
<FONT STYLE="white-space:nowrap">10b5-1</FONT> Plan entered into on a date before the date of the Underwriting Agreement; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(5) any transfer pursuant to a
domestic relations order or negotiated divorce settlement or otherwise by operation of law; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(6) any transfers made by the undersigned to the Company to
satisfy tax withholding obligations pursuant to the Company&#146;s equity incentive plans or arrangements disclosed in the Prospectus (as defined in the Underwriting Agreement) or to pay the exercise price of any options issued under any such plan
or arrangement which expires during the <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Period, provided, that any report under Section&nbsp;16(a) of the Exchange Act in connection with such transfer shall indicate, to the extent permitted by such
Section and the related rules and regulations, the reason for such disposition and that such transfer of common stock was solely to the Company; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(7)
any transfers in connection with a bona fide third party tender offer, merger, consolidation or other similar transaction made to all common stock holders involving a change of control of the issuer, provided that in the event that the tender offer,
merger, consolidation or other such transaction is not completed, the undersigned&#146;s Common Stock shall remain subject to the restrictions contained herein; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">provided, however, that in the case of any transfer described in clauses (1)&nbsp;and (5) above, it shall be a condition to the transfer that (A)&nbsp;the
transferee executes and delivers to Oppenheimer, acting on behalf of the Underwriters, not later than one business day prior to such transfer, a written agreement, in substantially the form of this agreement (it being understood that any references
to &#147;immediate family&#148; in the agreement executed by such transferee shall expressly refer only to the immediate family of the undersigned and not to the immediate family of the transferee) and otherwise satisfactory in form and substance to
Oppenheimer, and (B)&nbsp;no filing by any party under the Exchange Act or other public announcement shall be required or shall be made voluntarily in connection with such transfer, and if the undersigned is required to file a report under
Section&nbsp;16(a) of the Exchange Act reporting a reduction in beneficial ownership of shares of Common Stock or Beneficially Owned Shares or any securities convertible into or exercisable or exchangeable for Common Stock or Beneficially Owned
Shares during the <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Period (as the same may be extended as described above) under applicable securities laws, the undersigned shall clearly indicate in the footnotes thereto that (a)&nbsp;the filing
relates to the circumstances described as appropriate in clause (1)&nbsp;or (5) and (b)&nbsp;no shares were sold by the reporting person. For purposes of this paragraph, &#147;<B>immediate family</B>&#148; shall mean a spouse, child, grandchild or
other lineal descendant (including by adoption), father, mother, brother or sister of the undersigned; and &#147;<B>affiliate</B>&#148; shall have the meaning set forth in Rule 405 under the Securities Act of 1933, as amended (the
&#147;<B>Securities Act</B>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For avoidance of doubt, nothing in this Agreement prohibits the undersigned from exercising any options or warrants
to purchase Common Stock (which exercises may be effected on a cashless basis to the extent the instruments representing such options or warrants permit exercises on a cashless basis), it being understood that any Common Stock issued upon such
exercises will be subject to the restrictions of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In order to enable this covenant to be enforced, the undersigned hereby consents to the
placing of legends or stop transfer instructions with the Company&#146;s transfer agent with respect to any Common Stock or securities convertible into or exercisable or exchangeable for Common Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The undersigned further agrees that it will not, during the <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Period (as the same may be extended as described
above), make any demand or request for or exercise any right with respect to the registration under the Securities Act of any shares of Common Stock or other Beneficially Owned Shares or any securities convertible into or exercisable or exchangeable
for Common Stock or other Beneficially Owned Shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The undersigned acknowledges and agrees that the Underwriters have not provided any recommendation
or investment advice nor have the Underwriters solicited any action from the undersigned with respect to this offering of the Common Stock and the undersigned has consulted their own legal, accounting, financial, regulatory and tax advisors to the
extent deemed appropriate. The undersigned further acknowledges and agrees that, although the Underwriters may provide certain Regulation Best Interest and Form CRS disclosures or other related documentation to you in connection with this offering,
the Underwriters are not making a recommendation to you to participate in this offering or sell any shares of Common Stock at the price determined in this offering, and nothing set forth in such disclosures or documentation is intended to suggest
that any Underwriter is making such a recommendation. The undersigned further acknowledges and agrees that none of the Underwriters has made any recommendation or provided any investment or other advice to the undersigned with respect to this
Agreement or the subject matter hereof, and the undersigned has consulted its own legal, accounting, financial, regulatory, tax and other advisors with respect to this Agreement and the subject matter hereof to the extent the undersigned has deemed
appropriate. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This Agreement and all authority herein conferred are irrevocable and shall survive the death or incapacity
of the undersigned and shall be binding upon the heirs, personal representatives, successors and assigns of the undersigned. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The undersigned hereby
represents and warrants that the undersigned has full power and authority to enter into this Agreement and that this Agreement has been duly authorized (if the undersigned is not a natural person), executed and delivered by the undersigned and is a
valid and binding agreement of the undersigned. This Agreement and all authority herein conferred are irrevocable and shall survive the death or incapacity of the undersigned (if a natural person) and shall be binding upon the heirs, personal
representatives, successors and assigns of the undersigned. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This Agreement shall be governed by and construed in accordance with the internal laws of the
State of New York applicable to agreements made and to be performed in such state. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The undersigned shall be released from all obligations under this
Agreement (i)&nbsp;if the Underwriting Agreement does not become effective on or before February&nbsp;9, 2024 (provided, however, that the Company may extend the February&nbsp;9, 2024 date by up to three months with written notice to the undersigned
prior thereto), (ii) if the Underwriting Agreement (other than the provisions thereof which survive termination) shall terminate or be terminated prior to payment for and delivery of the securities to be sold thereunder, or (iii)&nbsp;if
Oppenheimer, on the one hand, or the Company, on the other hand, informs the other, prior to the execution of the Underwriting Agreement, that it has determined not to proceed with the offering contemplated by the Underwriting Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The undersigned acknowledges and agrees that whether or not any public offering of Common Stock actually occurs depends on a number of factors, including
market conditions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>[Signature page follows] </I></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Very truly yours,</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">(Name of Stockholder&#151;Please Print)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">(Signature)</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>[Signature Page to <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreement] </I></P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>3
<FILENAME>d739219dex51.htm
<DESCRIPTION>EX-5.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-5.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 5.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="33%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="29%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="9%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" COLSPAN="5">200 Clarendon Street</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" COLSPAN="5">Boston, Massachusetts 02116</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" COLSPAN="5">Tel: +1.617.948.6000 Fax: +1.617.948.6001</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" COLSPAN="5">www.lw.com</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="6"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" COLSPAN="5">FIRM / AFFILIATE OFFICES</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ROWSPAN="5">


<IMG SRC="g739219g0131002255256.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&#8195;&#8195;&#8195;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Austin</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Milan</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Beijing</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Munich</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&#8195;&#8195;&#8195;&#8195;&#8195;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Boston</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">New York</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Brussels</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Orange County</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Century City</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Paris</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Chicago</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Riyadh</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">January&nbsp;31, 2024</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Dubai</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">San Diego</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">D&uuml;sseldorf</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">San Francisco</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Frankfurt</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Seoul</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Hamburg</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Silicon Valley</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Hong Kong</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Singapore</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Houston</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Tel Aviv</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">American Superconductor Corporation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">London</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Tokyo</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">114 East Main Street</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Los Angeles</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Washington,&nbsp;D.C.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Ayer, Massachusetts 01432</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Madrid</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">Re:</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Registration Statement on Form <FONT STYLE="white-space:nowrap">S-3</FONT> (File No.</U><U></U><U><FONT
STYLE="white-space:nowrap">&nbsp;333-253611);</FONT> Up to 6,210,000 shares of Common Stock, par value $0.01 per share</U><SUP STYLE="font-size:75%; vertical-align:top"> </SUP> </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To the addressee set forth above: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have acted
as special counsel to American Superconductor Corporation, a Delaware corporation (the &#147;<B><I>Company</I></B>&#148;), in connection with the proposed issuance of up to 6,210,000 shares (the &#147;<B><I>Shares</I></B>&#148;) of common stock,
$0.01 par value per share (&#147;<B><I>Common Stock</I></B>&#148;), including up to 810,000 shares of Common Stock issuable upon exercise of the underwriters&#146; option to purchase additional shares. The Common Stock is included in a registration
statement on Form <FONT STYLE="white-space:nowrap">S-3</FONT> under the Securities Act of 1933, as amended (the &#147;<B><I>Act</I></B>&#148;), filed with the Securities and Exchange Commission (the &#147;<B><I>Commission</I></B>&#148;) on
February&nbsp;26, 2021 (Registration <FONT STYLE="white-space:nowrap">No.&nbsp;333-253611)</FONT> (as amended, the &#147;<B><I>Registration Statement</I></B>&#148;), a base prospectus dated June&nbsp;21, 2021 (the &#147;<B><I>Base
Prospectus</I></B>&#148;) and a prospectus supplement dated January&nbsp;30, 2024 filed with the Commission pursuant to Rule 424(b) under the Act (together with the Base Prospectus, the &#147;<B><I>Prospectus</I></B>&#148;). The Shares are being
sold pursuant to an underwriting agreement dated January&nbsp;30, 2024 between Oppenheimer&nbsp;&amp; Co. Inc., as representative of the several underwriters listed on Schedule A thereto, and the Company (the &#147;<B><I>Underwriting
Agreement</I></B>&#148;). This opinion is being furnished in connection with the requirements of Item 601(b)(5) of Regulation <FONT STYLE="white-space:nowrap">S-K</FONT> under the Act, and no opinion is expressed herein as to any matter pertaining
to the contents of the Registration Statement or the Prospectus, other than as expressly stated herein with respect to the issue of the Shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As such counsel, we have examined such matters of fact and questions of law as we have considered appropriate for purposes of this letter.
With your consent, we have relied upon certificates and other assurances of officers of the Company and others as to factual matters without having independently verified such factual matters. We are opining herein as to the Delaware General
Corporation Law (&#147;<B><I>DGCL</I></B>&#148;), and we express no opinion with respect to any other laws. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>January&nbsp;31, 2024 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Page 2 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g739219g0131001728718.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to the foregoing and the other matters set forth herein, it is our opinion that, as of the date
hereof, when the Shares shall have been duly registered on the books of the transfer agent and registrar therefor in the name or on behalf of the purchasers, and have been issued by the Company against payment therefor (not less than par value) in
the circumstances contemplated by the Underwriting Agreement, the issue and sale of the Shares will have been duly authorized by all necessary corporate action of the Company, and the Shares will be validly issued, fully paid and nonassessable. In
rendering the foregoing opinion, we have assumed that the Company will comply with all applicable notice requirements regarding uncertificated shares provided in the DGCL. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This opinion is for your benefit in connection with the Registration Statement and may be relied upon by you and by persons entitled to rely
upon it pursuant to the applicable provisions of the Act. We consent to your filing this opinion as an exhibit to the Company&#146;s Form <FONT STYLE="white-space:nowrap">8-K</FONT> dated as of the date hereof, and to the reference to our firm in
the Prospectus under the heading &#147;Legal Matters.&#148; In giving such consent, we do not thereby admit that we are in the category of persons whose consent is required under Section&nbsp;7 of the Act or the rules and regulations of the
Commission thereunder. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Sincerely,</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">/s/ LATHAM&nbsp;&amp; WATKINS LLP</P></TD></TR>
</TABLE></DIV>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>amsc-20240130.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20231012.2 -->
<!-- Creation date: 1/31/2024 8:24:28 PM Eastern Time -->
<!-- Copyright (c) 2024 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2023"
  xmlns:amsc="http://www.amsc.com/20240130"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://www.amsc.com/20240130"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" namespace="http://xbrl.sec.gov/dei/2023" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2023/naics-2023.xsd" namespace="http://xbrl.sec.gov/naics/2023" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="amsc-20240130_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="amsc-20240130_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.amsc.com//20240130/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>amsc-20240130_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20231012.2 -->
<!-- Creation date: 1/31/2024 8:24:28 PM Eastern Time -->
<!-- Copyright (c) 2024 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>amsc-20240130_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20231012.2 -->
<!-- Creation date: 1/31/2024 8:24:28 PM Eastern Time -->
<!-- Copyright (c) 2024 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.amsc.com//20240130/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="amsc-20240130.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.amsc.com//20240130/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="24.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>g739219g0131001728718.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g739219g0131001728718.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  + *(# 2(  A$! Q$!_\0
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MBU\.Z)8W*7%IH^GV\Z9VRQ6J(RY&#@@9'%78K:WMXWCA@BC1V+LJ( &8G))
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MREB5$=O@9X'RUM'3K(_9\V=N?LW^H_=+^Z_W>/E_"I$MX(YY)TAC6:0 /(%
M9L=,GJ<4*+05*\9-M+=6_&YY-!=WNAZ!J5[)-+)INI_:X'))/V:<%U1O96
M^HKL+S2[S5_"6CK;31EHECED@G=ECN0%^XQ7GW[CCD5TITZQ-F]F;*W-JY)>
M$Q+L8DY.5Q@\\TRZTK3KZT2UN["VGMXR"D4L2LJXZ8!&!24&C2>*C-II6=S'
M\/ZG#<: KV&G_8XX+AH)((AYBJ0V&V%?O#/<"KTL^I31HELNR87#AS(A51'\
M^PY(.>B9QSSVK2@@AMH$AMXDBB085(U"JH]@.E25:6AS2FG)M(****9F?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>g739219g0131002255256.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g739219g0131002255256.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  0 .L# 2(  A$! Q$!_\0
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MD@:.ZA\R*6-]I8$ @@Y4<_4&HO#7AV7P^MRK7OVA9V5]OED>40,;5)).P
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CH?6MV&RM;>)8H+:&*->B)& !^ JVI/;0YU*A'=7^=NQ__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140493295179280">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Jan. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">AMERICAN SUPERCONDUCTOR CORP /DE/<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000880807<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jan. 30,  2024<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">000-19672<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">04-2959321<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">114 East Main Street<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Ayer<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">01432<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(978)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">842-3000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, $0.01 par value per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">AMSC<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>11
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M4$L! A0#%     @ >H(_6,(HGQ+N    *P(  !$              ( !KP
M &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ >H(_6)E<G",0!@  G"<
M !,              ( !S $  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4
M    " !Z@C]82;!Z)58$  "8$   &               @($-"   >&PO=V]R
M:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ >H(_6)^@&_"Q @  X@P
M  T              ( !F0P  'AL+W-T>6QE<RYX;6Q02P$"% ,4    " !Z
M@C]8EXJ[',     3 @  "P              @ %U#P  7W)E;',O+G)E;'-0
M2P$"% ,4    " !Z@C]8'#AEZC\!   \ @  #P              @ %>$
M>&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ >H(_6"0>FZ*M    ^ $  !H
M             ( !RA$  'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L!
M A0#%     @ >H(_6&60>9(9 0  SP,  !,              ( !KQ(  %M#
G;VYT96YT7U1Y<&5S72YX;6Q02P4&      D "0 ^ @  ^1,

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d739219d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amsc.com//20240130/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>amsc-20240130.xsd</File>
    <File>amsc-20240130_lab.xml</File>
    <File>amsc-20240130_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" original="d739219d8k.htm">d739219d8k.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>18
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "d739219d8k.htm": {
   "nsprefix": "amsc",
   "nsuri": "http://www.amsc.com/20240130",
   "dts": {
    "schema": {
     "local": [
      "amsc-20240130.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd",
      "https://xbrl.sec.gov/naics/2023/naics-2023.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "amsc-20240130_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "amsc-20240130_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "d739219d8k.htm"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 3,
    "http://xbrl.sec.gov/dei/2023": 3
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 23,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 22
   },
   "report": {
    "R1": {
     "role": "http://www.amsc.com//20240130/taxonomy/role/DocumentDocumentAndEntityInformation",
     "longName": "100000 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "duration_2024-01-30_to_2024-01-30",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d739219d8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "duration_2024-01-30_to_2024-01-30",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d739219d8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.amsc.com//20240130/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.amsc.com//20240130/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "terseLabel": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.amsc.com//20240130/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://www.amsc.com//20240130/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "terseLabel": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.amsc.com//20240130/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.amsc.com//20240130/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.amsc.com//20240130/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.amsc.com//20240130/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.amsc.com//20240130/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.amsc.com//20240130/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.amsc.com//20240130/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "terseLabel": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.amsc.com//20240130/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.amsc.com//20240130/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.amsc.com//20240130/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.amsc.com//20240130/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.amsc.com//20240130/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.amsc.com//20240130/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.amsc.com//20240130/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.amsc.com//20240130/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.amsc.com//20240130/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.amsc.com//20240130/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.amsc.com//20240130/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "terseLabel": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>19
<FILENAME>0001193125-24-020938-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-24-020938-xbrl.zip
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M^V+U(\RV9[B[&<YZ>]7N&OKY#U!+ P04    " !Z@C]8"Y@3=E\&  "^0P
M%0   &%M<V,M,C R-# Q,S!?;&%B+GAM;,V<76_;-A2&[POT/YQY-QM0V;'3
MB]9H6F1.,@3+%Q)W&S8,A2PQ-C&*-$@YL?_]2'TT<DS)4G@TY:*I(IWSGO,Z
MSV%HV<ZG+^N(P0.1B@I^U!OV#WI >"!"RN='O97R?!50V@,5^SSTF>#DJ+<A
MJO?E\]LWGW[P/#@Y.[\"#Q9QO%3CP>#Q\;$?WE.N!%O%6E+U Q$-P//R^,GT
M*_R>EAO#+6'$5P0B7\5$PB\KRL+QZ&!T.#P8COJC8IHDOM&#T(_)&(:#P^%
M![Z'#^/1^_'H ]Q<PFFBPF%*(U),%<N-I/-%##\%/T.2="(X)XR1#9Q1[O.
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MDD)FZ\C6CVYELLA &/?9$>F=,,RL>V(B59;W(B!Y0ELS!9-V8$.&+IKU\NT
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M['H$?G .2@;>%;WS<17I.GD7GF<0GK4H.YBC3OOJEG3:-]>=V]<W/C>)D G
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MBD8B#;2 (XM#IK>_C_1>0[3F?.\*:9 %4YRC08_=HUE+UNH6#T^: EYO0+R
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MS!<$GH*.YJ>GL\30.IL0$+:[O5.K;8-],V&'3(G-<5.7=GDF;)$F;)D$+#:
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M1-&^-)4Y0Y?YODT>V>S$N7;6IJ%O?]:@DO.JS_0>RJ\X#JVO$(;^^,8BRID
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MU5_21/^5'  #VT3SM[/7K_*L3MYDLP(^SLK9>/0K4-\B7^;ESQO&O@T^].(
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M<ABZOAU/X-FLYO?AA/QG_ZK1LI$K^SO&@EN25[U*TV!&0<<TCR$X>4=MYX[
M.U2_-"H-*898H0BGY0?S]T;)?)5=^2+M.>O[6KV>N/+G0J#%NP.J0GMKRFP(
M,-17P'RKC.T*!/6WW5V#\(!,UB!OW<EQ;<\&S3>BV=ZY 5.K(_0(]@9U!O1
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MD^3:_7K^%B8D,!Y@+7E@0XIRYM8#?-PA=R;S=;NNO0H=#4IZ%HZRH6"BYHO
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MLJ:IINR#]H$FHY9Q'@1LGO0E51]9[L$9W"+\:\&$B;X7N;N^Q?TL:1;%3 B
MBE2+*1:'Q6B"X1[+AKI'HQNX/ -:&&PYXX<(S\#,J%#3ZB);=([3-\T#PKL
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M[QM)D  GM''(9BHA<(M(1(@#Y7<6$G/15Y:8-YB\H<)-450DUPIM6ZW%=5#
M QK'KJ1$/D\7U# 5HY;YLB(8DA+/0-!IF )XO^GD#<=-KM7!, "F+C M[,S(
M>NG5:",RBD"",^%UX$_PIYOJ]Y(H7&,?$6H(<-3:]W%'P8>CP_<ODQ!C#^^,
M#\XI>+^#T6/?F.KLN 3G96ZO5JZZKR")YOL]FYB4..@Y"CP54N(3U1P6K( (
M#C*R2X@"'P'U(W<N!I+Q=-T#T99?W^#@N@%0SGU<3T:+?XD1J@>O,,X6NZGO
M)?&UEV>^.7%T8W[K< 2B[9>#1R^Z7NI.XOR$UC+#M2QD#3YS/LH<=M3'B'P#
MSX>_S*F)M5B$XMYDL.MEGSB%'Z.%=E$M+J@2E@I<FD[_)[C9A4*KF2C2C (E
M/ 5!?^*F&OEL@*2!M;JN[-<FS%@NL.Y QNLGNQ@+%PF,H;VL/'R*A<)NV+$$
MG+C:OG?[Z;\\BQG8;1^+52U!?&]@F5X1PQ;J\$V8XW($UXX)9&5K.PYO$)M!
M_,$ F\\[F.>!L_>'^^ \##[^GC-!U 8[\H$_'\?:IAU%]BFS(<0-JIR$!8_.
MLP+CAB[&\;+*ZAEW,<L;]IFH:#TZ+_)Y\MJ=LZP@42E8^$;*[GY.,] X78=>
MS7[I1D KVR7'?L'822IN-P7CDNO$XFRR">$;9A=5,=/\E5FUGDBUT'9W__XU
MZ@A,CT0%UI,88S>6Q@7N$DOKQ\2:MFC785 ,MMV%Q;;$P;!;B(.2]BD\&&*1
M?DI1]-;^#=/N1^$/XH(-&**6][BF?[AKSIM_B.DCL-ICP00W^%*Q%7+AC E[
M<2*=Q+B5)]NYC$=N,M<,\FMB3Y#GD) ;F"/BW/VJ:].<9TTG6(?G:%" N!"'
M ;]FW0I B0EQ1)8<Z[[T$"G$_<XD2+2]@,5XU$&0"2"APG-!XDJ#!GE]T;3$
M%#141' 3&.8_#AA]K<CH-L?^ )$XW!LW 46$)2!J;A9)IXGH2M%L-'=[%9LZ
M;#K)"6"X?V +U O;,=BE\:32_]"8N1/.C)JVVG,#=1ODS8/4[JNE>V7<U].<
M[Z%Y1M&+Q(6K8?GUT:EKEG[01=WL2CJ[-$HAW_Z-&ZUT=%=-R_ 21^ I[+4N
M0T2)2'\ 8M4@GL1THN["5>-0O^H CX8*#%4Q)/X[)P\)$!#>7 I/+*IJYK("
MQJ-IMLB6!-35J>#2N":J5B4LE*NH$'Q8^^01'!E!UJVU==^Z)K9QAK\M\00P
ME#1E+LJ2EB[%%-A6:L'M"&OL6O3:A:AG]N-AP;R(,S=2H61 DRA:(A3)/$54
M^ <8N)92_5YK[Z%#LEC%\K:54U9%"CB 6>'24BZL^!H[ _00N( 'HO\J-0;H
M\)@ O>)S^QT>I'\BIHKG1-X^RH+FZ/H;CK1FK'Z(V-:9I*Y5A. 4(6I(F9V)
M>=YGGVG064 L!(6+JY-=&&O4(;,+_8Q'VTJ1%)/8=GEWZ(IDF 40O@Z'3A5_
M[H?M]!EC&V!KL,*'1;OH13T8HBH,OF;"!K/&1;FQ2<;2- 5B'@ /"IABZW2_
M\<A9-9QW6P_4.4IFDL_(4P]75I9Y'2W<'=[1>XC;_J;B0LI$EBM0=,5/,AZ=
M2+&GYF\(Z^DIO5SM(.HR]6I'B;%&\5NOL>"^]JA#! ]$)D+G)7F9H4Q&9RA<
M>5%..*M-ZF,#+DBD3F]%_R96DTR)_B?5[$J\#2SZ)8V/]MI##]?]ZB0% T*I
M]=NZ%"Z+2$,UR I. Q2.*_]@5Q-SK#)#_$F=ZCR?T:%6TDQ"63G5@:URRE(/
M>K8,Y//=:"$$SR2TO[BRU+^X$BY$NFA%F.W<B7+;\Y9E<3!C@+?<6W<,($=T
M#0)WF F!?NQIQYN;^(U'ML3!V[$S>:T 6NJY.-.H*.V"?6&#9C> - 8-*JDS
MS1TEJT;QG3"?+8_6/I"H-+5D0DOL_=&N+12HF59G)>S6C,W[AIIN^/'.LE*S
M)Q3S1Z!622(7!A&L9X"2A2O&+1TM6]E/?M@[V]][O+E564>#*"5"9"=D][/7
M24 @305L@LVF!JO5BL5"B5T*#ZV:0/_C-_@&!BPM*9F/\A655,>C#+]K"#UC
MO9)CWD]O?J+*!:+5+ITC_0.'N'_X,\1]"^BKC-+4 T2Z+N<*_#R!GCX>A;PJ
M:,0AM0,_FPI+#RDW3,2&)77%E/CY6%H;&:*]KOO\!9Y#[^D&#"O.*_03,\/[
MIH^B:&EO2T'7<3B&Z>8!PB\[GQZ),2-G);?]W3\^'B=O__8I>?/FR'@:ML;Q
MMSZ 2LT#>-4#\OIC8$BZ.7'H?QG=$S)!;"^-GL^6"CR_>L_)?<_WFI1""UR"
MFK5<+_F)K_1/@C5LS"?C$8%XLYSB+WN:I'8HRF>Z$R2(['9(P@&=<*0:81+Y
MR=+1@PAFED%&"R7=LV>N<SICBSY'LA&MWF<[!V;))"N_X!-8OPTO+&#]-GV,
M%N=PBV 2K[M:IHXE[54R;P+-BJ9>LR6-PM7J,@9C72=0!8#S8 6V"Y<U/5WD
M6<T9!MS0T-G;GTNZ\^1^#SM*][Z-Y=_[.N#S"E2:A;3>H3C<N:\N(WF+E@@1
M?5[7L.!F*<G(GA=:?P5"E).L(:NX!@)!+PU''(/1C"4?6=#P"'(JOKK:-]F#
M?:N=<7*9U;Z\TF['T*M173G/LP5H-/FJF.5+[OT)EUS^;196E.1?J-:$ZDC
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M%Y:*A*Y,WVD^*<1>*V@$6_YOL6XHQ2H_JZC#U+MJD$/YGM'D3:=*F1T-;P(
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M-L*UO4XBRI0\\\AN+HO.V@T3"]IA4C7VG+&2P@R8(L59GNDDOR>JE8TQM$3
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M0B=6[R*>*7!#&HB(,:4Q$E/5%X!+%%1=5M1D=Z1S)E_"AG2WX@@:V:4(T<-
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M)HQHV.KFV;1+:OT'XWFZ[N8CV8X\?T,XHS$F]+ET Y.0Z<>#00T#4*$P2?"
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MZ0K._C,\^X='IX,]7= &/,"R%9+;MJN8JQ1%F,A+V(I^+XNIA'?2ZSDS>;1
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M\"P)HE66'N46[:/<5=>D7 "$Q+VID9S=$#B]7]K?&;Q-T0,YL:/%F,&%7,A
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M9'/+ ;7L;?,CW#0_7?T?4$L! A0#%     @ >H(_6->3S7$[ P  0 L  !$
M             ( !     &%M<V,M,C R-# Q,S N>'-D4$L! A0#%     @
M>H(_6 N8$W9?!@  OD,  !4              ( !:@,  &%M<V,M,C R-# Q
M,S!?;&%B+GAM;%!+ 0(4 Q0    ( 'J"/UA/=0FKM 0  '0J   5
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-  8 ?0$  .#3      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>d739219d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="amsc-20240130.xsd" xlink:type="simple"/>
    <context id="duration_2024-01-30_to_2024-01-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880807</identifier>
        </entity>
        <period>
            <startDate>2024-01-30</startDate>
            <endDate>2024-01-30</endDate>
        </period>
    </context>
    <dei:EntityRegistrantName
      contextRef="duration_2024-01-30_to_2024-01-30"
      id="Hidden_dei_EntityRegistrantName">AMERICAN SUPERCONDUCTOR CORP /DE/</dei:EntityRegistrantName>
    <dei:AmendmentFlag contextRef="duration_2024-01-30_to_2024-01-30" id="ixv-307">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2024-01-30_to_2024-01-30"
      id="Hidden_dei_EntityCentralIndexKey">0000880807</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2024-01-30_to_2024-01-30" id="ixv-318">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2024-01-30_to_2024-01-30" id="ixv-319">2024-01-30</dei:DocumentPeriodEndDate>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2024-01-30_to_2024-01-30" id="ixv-320">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2024-01-30_to_2024-01-30" id="ixv-321">000-19672</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2024-01-30_to_2024-01-30" id="ixv-322">04-2959321</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2024-01-30_to_2024-01-30" id="ixv-323">114 East Main Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="duration_2024-01-30_to_2024-01-30" id="ixv-324">Ayer</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2024-01-30_to_2024-01-30" id="ixv-325">MA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2024-01-30_to_2024-01-30" id="ixv-326">01432</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2024-01-30_to_2024-01-30" id="ixv-327">(978)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2024-01-30_to_2024-01-30" id="ixv-328">842-3000</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2024-01-30_to_2024-01-30" id="ixv-329">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2024-01-30_to_2024-01-30" id="ixv-330">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2024-01-30_to_2024-01-30" id="ixv-331">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2024-01-30_to_2024-01-30" id="ixv-332">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2024-01-30_to_2024-01-30" id="ixv-333">Common Stock, $0.01 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2024-01-30_to_2024-01-30" id="ixv-334">AMSC</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2024-01-30_to_2024-01-30" id="ixv-335">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2024-01-30_to_2024-01-30" id="ixv-336">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
